200,000+ products from a single source!
sales@angenechem.com
28797-61-7 | 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-
CAS No: 28797-61-7 Catalog No: AG002WJ9 MDL No:
Product Description
Catalog Number:
AG002WJ9
Chemical Name:
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-
CAS Number:
28797-61-7
Molecular Formula:
C19H21N5O2
Molecular Weight:
351.4023
IUPAC Name:
11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
InChI:
InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)
InChI Key:
RMHMFHUVIITRHF-UHFFFAOYSA-N
SMILES:
CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2
EC Number:
249-228-4
UNII:
3G0285N20N
Properties
Complexity:
534
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
351.17g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
351.41g/mol
Monoisotopic Mass:
351.17g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
68.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.1
Literature
| Title | Journal |
|---|---|
| Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. | European journal of medicinal chemistry 20130501 |
| Modulating rheological and degradation properties of temperature-responsive gelling systems composed of blends of PCLA-PEG-PCLA triblock copolymers and their fully hexanoyl-capped derivatives. | Acta biomaterialia 20121201 |
| Role of M3 mAChR in in vivo and in vitro models of LPS-induced inflammatory response. | International immunopharmacology 20121101 |
| Muscarinic acetylcholine receptor-mediated effects in slices from human epileptogenic cortex. | Neuroscience 20121025 |
| Adenosine A(2A) receptor antagonists are broad facilitators of antinicotinic neuromuscular blockade monitored either with 2 Hz train-of-four or 50 Hz tetanic stimuli. | Clinical and experimental pharmacology & physiology 20121001 |
| Muscarinic receptor subtypes involved in urothelium-derived relaxatory effects in the inflamed rat urinary bladder. | Autonomic neuroscience : basic & clinical 20120925 |
| Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase. | Journal of neurochemistry 20120901 |
| Muscarinic antagonist control of myopia: evidence for M4 and M1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew. | Investigative ophthalmology & visual science 20120824 |
| Effects of muscarinic receptor antagonists on acetylcholine-induced contractions of jejunal smooth muscle in horses. | Journal of veterinary pharmacology and therapeutics 20120801 |
| Acute desensitization of acetylcholine and endothelin-1 activated inward rectifier K+ current in myocytes from the cardiac atrioventricular node. | Biochemical and biophysical research communications 20120706 |
| Influence of experimental periodontitis on cholinergic stimulation of K⁺ release in rat parotid glands. | Autonomic neuroscience : basic & clinical 20120702 |
| Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys. | Neurobiology of learning and memory 20120701 |
| Nornicotine application on cockroach dorsal unpaired median neurons induces two distinct ionic currents: implications of different nicotinic acetylcholine receptors. | Neuroscience letters 20120614 |
| Activation of muscarinic receptors increases the activity of the granule neurones of the rat dorsal cochlear nucleus--a calcium imaging study. | Pflugers Archiv : European journal of physiology 20120601 |
| Calcium-dependent but action potential-independent BCM-like metaplasticity in the hippocampus. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120516 |
| Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120501 |
| Characterization of 5-hydroxytryptamine-induced contraction and acetylcholine-induced relaxation in isolated chicken basilar artery. | Poultry science 20120501 |
| Functional role of muscarinic receptor subtypes in calcium sensitization and their contribution to rho-kinase and protein kinase C pathways in contraction of human detrusor smooth muscle. | Urology 20120501 |
| Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart. | Pflugers Archiv : European journal of physiology 20120401 |
| Interindividual variation in olanzapine concentration influenced by UGT1A4 L48V polymorphism in serum and upstream FMO polymorphisms in cerebrospinal fluid. | Journal of clinical psychopharmacology 20120401 |
| Aclidinium inhibits human lung fibroblast to myofibroblast transition. | Thorax 20120301 |
| Protein kinase C activity alters the effect of μ-opioid receptors on inhibitory postsynaptic current in the striosomes. | Neuroreport 20120215 |
| Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats. | Behavioural brain research 20120201 |
| Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. | Cell research 20120201 |
| Participation of hippocampal cholinergic system in memory persistence for inhibitory avoidance in rats. | Neurobiology of learning and memory 20120201 |
| Cholinergic suppression of excitatory synaptic transmission in layers II/III of the parasubiculum. | Neuroscience 20120110 |
| Muscarinic receptor agonists and antagonists: effects on ocular function. | Handbook of experimental pharmacology 20120101 |
| Expanding the multipotent profile of huprine-tacrine heterodimers as disease-modifying anti-Alzheimer agents. | Neuro-degenerative diseases 20120101 |
| Ocular medicines in children: the regulatory situation related to clinical research. | BMC pediatrics 20120101 |
| FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists. | PloS one 20120101 |
| Effects of deoxycholylglycine, a conjugated secondary bile acid, on myogenic tone and agonist-induced contraction in rat resistance arteries. | PloS one 20120101 |
| Recent advances in noncardiac chest pain in Korea. | Gut and liver 20120101 |
| Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems. | PloS one 20120101 |
| CheS-Mapper - Chemical Space Mapping and Visualization in 3D. | Journal of cheminformatics 20120101 |
| Endocannabinoid-dopamine interactions in striatal synaptic plasticity. | Frontiers in pharmacology 20120101 |
| Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex. | BMC neuroscience 20120101 |
| [Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization]. | Urologia 20120101 |
| Striatal input- and rate-dependent effects of muscarinic receptors on pallidal firing. | TheScientificWorldJournal 20120101 |
| Effects of PPARγ Ligands on Leukemia. | PPAR research 20120101 |
| Role of various subtypes of muscarinic cholinergic receptors in the development of posthemorrhagic abnormalities in systemic and portal circulation in rats. | Bulletin of experimental biology and medicine 20120101 |
| Characterization of a new muscarinic toxin from the venom of the Brazilian coral snake Micrurus lemniscatus in rat hippocampus. | Life sciences 20111219 |
| Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell. | Endocrinology 20111201 |
| Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol. | Urology 20111201 |
| The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of action. | Pain 20111201 |
| (2R,3R)-1-(4-Chloro-phen-yl)-2-[(S)-2-nitro-1-phenyl-eth-yl]-3-phenyl-pentan-1-one. | Acta crystallographica. Section E, Structure reports online 20111201 |
| Muscarinic receptor subtypes involved in regulation of colonic motility in mice: functional studies using muscarinic receptor-deficient mice. | European journal of pharmacology 20111116 |
| M3-receptor activation counteracts opioid-mediated apneusis, but the apneusis per se is not necessarily related to an impaired M3 mechanism in rats. | Life sciences 20111107 |
| Role of M1 receptor in regulation of gastric fundus smooth muscle contraction. | Postepy higieny i medycyny doswiadczalnej (Online) 20110914 |
| The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice. | Behavioural pharmacology 20110901 |
| Intracellular distribution of functional M(1) -muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells. | Journal of neurochemistry 20110901 |
| [Myopia update 2011]. | Klinische Monatsblatter fur Augenheilkunde 20110901 |
| Modulating activity of M1 receptor to the reaction of ileal smooth muscle. | Postepy higieny i medycyny doswiadczalnej (Online) 20110803 |
| Differing time dependencies of object recognition memory impairments produced by nicotinic and muscarinic cholinergic antagonism in perirhinal cortex. | Learning & memory (Cold Spring Harbor, N.Y.) 20110701 |
| A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. | Psychopharmacology 20110601 |
| Analgesic and antineuropathic drugs acting through central cholinergic mechanisms. | Recent patents on CNS drug discovery 20110501 |
| Importance of physicochemical properties for the design of new pesticides. | Journal of agricultural and food chemistry 20110413 |
| Vasorelaxation by extracts of Casimiroa spp. in rat resistance vessels and pharmacological study of cellular mechanisms. | Journal of ethnopharmacology 20110412 |
| Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. | The American journal of tropical medicine and hygiene 20110405 |
| BK channel β1 subunits regulate airway contraction secondary to M2 muscarinic acetylcholine receptor mediated depolarization. | The Journal of physiology 20110401 |
| The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine. | British journal of clinical pharmacology 20110401 |
| An evidence-based update on myopia and interventions to retard its progression. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20110401 |
| Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation. | British journal of pharmacology 20110201 |
| Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice. | Peptides 20110201 |
| Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats. | Molecular and cellular endocrinology 20110101 |
| The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20110101 |
| Presynaptic muscarinic receptor subtypes involved in the enhancement of spontaneous GABAergic postsynaptic currents in hippocampal neurons. | The European journal of neuroscience 20110101 |
| Centrality of striatal cholinergic transmission in Basal Ganglia function. | Frontiers in neuroanatomy 20110101 |
| Inhibition of granulocyte migration by tiotropium bromide. | Respiratory research 20110101 |
| Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment. | Molecular vision 20110101 |
| Defining the buffering process by a triprotic acid without relying on Stewart-electroneutrality considerations. | Theoretical biology & medical modelling 20110101 |
| Colonic inflammation increases the contribution of muscarinic M2 receptors to carbachol-induced contraction of the rat colon. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20110101 |
| Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland. | Dental research journal 20110101 |
| ATP competitive protein kinase C inhibitors demonstrate distinct state-dependent inhibition. | PloS one 20110101 |
| Cholinergic partition cells and lamina x neurons induce a muscarinic-dependent short-term potentiation of commissural glutamatergic inputs in lumbar motoneurons. | Frontiers in neural circuits 20110101 |
| Modulation of peripheral inflammatory pain thresholds by M(1) and nicotinic receptor antagonists. | Pharmacology 20110101 |
| Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. | Molecular vision 20110101 |
| Interventions to slow progression of myopia in children. | The Cochrane database of systematic reviews 20110101 |
| Indigenous anti-ulcer activity of Musa sapientum on peptic ulcer. | Pharmacognosy research 20110101 |
| Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated by inhibition of SK channels. | Neuron 20101209 |
| The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20101208 |
| Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability. | The Journal of pharmacology and experimental therapeutics 20101201 |
| Cholinergic modulation of neuronal excitability in the accessory olfactory bulb. | Journal of neurophysiology 20101201 |
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | Healthcare informatics research 20101201 |
| Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid. | Journal of pharmaceutical and biomedical analysis 20101102 |
| The effect of pirenzepine on positive- and negative-lens-induced refractive error and ocular growth in chicks. | Investigative ophthalmology & visual science 20101101 |
| Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. | Bioorganic & medicinal chemistry 20101101 |
| Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis. | Urology 20101001 |
| M₃muscarinic receptors mediate acetylcholine-induced pulmonary vasodilation in pulmonary hypertension. | Bioscience trends 20101001 |
| Effects of benzodiazepine treatment on cortical GABA(A) and muscarinic receptors: studies in schizophrenia and rats. | Psychiatry research 20100930 |
| Knockdown of zebrafish lumican gene (zlum) causes scleral thinning and increased size of scleral coats. | The Journal of biological chemistry 20100903 |
| M(1)-like muscarinic acetylcholine receptors regulate fast-spiking interneuron excitability in rat dentate gyrus. | Neuroscience 20100811 |
| Cholinergic modulation differs between basal and apical dendritic excitation of hippocampal CA1 pyramidal cells. | Cerebral cortex (New York, N.Y. : 1991) 20100801 |
| Parasympathetic influence plays an independent and significant role in inducing the contraction of the seminal vesicle of the rat. | Urology 20100801 |
| Molecular dynamics simulation of condensed-phase chiral molecular propellers. | The journal of physical chemistry. B 20100701 |
| The interaction of intrathecal neostigmine and N-cyclohexyladenosine on anti-allodynic effects in rats with a nerve ligation injury. | Korean journal of anesthesiology 20100701 |
| Muscarinic receptor type 1 (M1) stimulation, probably through KCNQ/Kv7 channel closure, increases spontaneous GABA release at the dendrodendritic synapse in the mouse accessory olfactory bulb. | Brain research 20100621 |
| A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor. | Assay and drug development technologies 20100601 |
| Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform. | ACS chemical biology 20100416 |
| Activation of muscarinic M-1 cholinoceptors by curcumin to increase contractility in urinary bladder isolated from Wistar rats. | Neuroscience letters 20100405 |
| Autoantibodies from schizophrenia patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3 production. | The international journal of neuropsychopharmacology 20100401 |
| Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists. | Bioorganic & medicinal chemistry letters 20100401 |
| Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP. | European journal of oral sciences 20100401 |
| Decreased kainate receptors in the hippocampus of apolipoprotein D knockout mice. | Progress in neuro-psychopharmacology & biological psychiatry 20100317 |
| Muscarinic cholinoceptor activation by pilocarpine triggers apoptosis in human skin fibroblast cells. | Journal of cellular physiology 20100301 |
| Overexpression of serine acetlytransferase produced large increases in O-acetylserine and free cysteine in developing seeds of a grain legume. | Journal of experimental botany 20100301 |
| [Effect on of pirenzepine on expression of mAChRs in the ocular tissues of guinea pig with form-deprived myopia]. | [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20100301 |
| Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. | Proceedings of the National Academy of Sciences of the United States of America 20100209 |
| AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model. | Neuropharmacology 20100201 |
| Role of surface free energy and spreading coefficient in the formulation of active agent-layered pellets. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100201 |
| Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. | Cell death & disease 20100201 |
| Apamin reduces neuromuscular transmission by activating inhibitory muscarinic M(2) receptors on motor nerve terminals. | European journal of pharmacology 20100125 |
| Natural compounds endowed with cholinergic or anticholinergic activity. Enhancement of acetylcholine release by a quaternary derivative of L-hyoscyamine. | Journal of molecular neuroscience : MN 20100101 |
| Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats. | Journal of biomedical science 20100101 |
| Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. | PloS one 20100101 |
| Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens. | Molecular vision 20100101 |
| Sultr4;1 mutant seeds of Arabidopsis have an enhanced sulphate content and modified proteome suggesting metabolic adaptations to altered sulphate compartmentalization. | BMC plant biology 20100101 |
| Training regimen involving cyclic induction of pupil constriction during far accommodation improves visual acuity in myopic children. | Clinical ophthalmology (Auckland, N.Z.) 20100101 |
| Predictable patterns of trait mismatches between interacting plants and insects. | BMC evolutionary biology 20100101 |
| Recruitment and retention of women in a large randomized control trial to reduce repeat preterm births: the Philadelphia Collaborative Preterm Prevention Project. | BMC medical research methodology 20100101 |
| M1 muscarinic receptor for the development of auditory cortical function. | Molecular brain 20100101 |
| Constitutive overexpression of muscarinic receptors leads to vagal hyperreactivity. | PloS one 20100101 |
| Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected]. | Clinical practice and epidemiology in mental health : CP & EMH 20100101 |
| Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II. | Current neuropharmacology 20091201 |
| Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats. | Neuroscience letters 20091120 |
| Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. | Molecular psychiatry 20091101 |
| Agonist actions of clothianidin on synaptic and extrasynaptic nicotinic acetylcholine receptors expressed on cockroach sixth abdominal ganglion. | Neurotoxicology 20091101 |
| Effects of cholinesterase inhibition in supraspinal and spinal neural pathways on the micturition reflex in rats. | BJU international 20091001 |
| Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. | Bioorganic & medicinal chemistry 20091001 |
| Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology. | International journal for parasitology 20090901 |
| Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex. | The Journal of pharmacology and experimental therapeutics 20090901 |
| Cytoplasmic Ca(2+) concentration changes evoked by cholinergic stimulation in primary astrocyte cultures prepared from the rat cochlear nucleus. | Hearing research 20090901 |
| Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate. | Neuroscience letters 20090814 |
| Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090801 |
| Functional characterization of muscarinic autoreceptors in rat and human neocortex. | Journal of neurochemistry 20090801 |
| Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process. | The Journal of biological chemistry 20090717 |
| Spinal cholinergic mechanism of the relieving effects of electroacupuncture on cold and warm allodynia in a rat model of neuropathic pain. | The journal of physiological sciences : JPS 20090701 |
| A cholinergic-dependent role for the entorhinal cortex in trace fear conditioning. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20090624 |
| Treatment options for myopia. | Optometry and vision science : official publication of the American Academy of Optometry 20090601 |
| An increase in intracelluar free calcium ions modulated by cholinergic receptors in rat facial nucleus. | Chinese medical journal 20090505 |
| Salivation triggered by pilocarpine involves aquaporin-5 in normal rats but not in irradiated rats. | Clinical and experimental pharmacology & physiology 20090501 |
| Presynaptic muscarinic receptors enhance glutamate release at the mitral/tufted to granule cell dendrodendritic synapse in the rat main olfactory bulb. | Journal of neurophysiology 20090401 |
| Functional characterization of the muscarinic receptors involved in endothelium-dependent relaxation in isolated canine uterine artery. | Journal of veterinary pharmacology and therapeutics 20090401 |
| Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors. | British journal of pharmacology 20090401 |
| [Mechanism of Smad 3 signaling pathway and connective tissue growth factor in the inhibition of form deprivation myopia by pirenzepine]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20090401 |
| Regional changes in the cholinergic system in mice lacking monoamine oxidase A. | Brain research bulletin 20090330 |
| The medial amygdaloid nucleus modulates cardiovascular responses to acute restraint in rats. | Neuroscience 20090317 |
| Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking. | Behavioural brain research 20090302 |
| [Characterization of muscarinic receptors in undifferentiated thyroid cells in Fisher rats]. | Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20090301 |
| [Refractive errors]. | La Revue du praticien 20090220 |
| Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors. | Progress in neuro-psychopharmacology & biological psychiatry 20090201 |
| Muscarinic cholinergic modulation of synaptic transmission and plasticity in rat hippocampus following chronic lead exposure. | Naunyn-Schmiedeberg's archives of pharmacology 20090101 |
| Acetylcholine activity in selective striatal regions supports behavioral flexibility. | Neurobiology of learning and memory 20090101 |
| Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin. | Cell biology international 20090101 |
| Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice. | British journal of pharmacology 20090101 |
| Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia. | Molecular vision 20090101 |
| Enhanced muscarinic M1 receptor gene expression in the corpus striatum of streptozotocin-induced diabetic rats. | Journal of biomedical science 20090101 |
| [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers]. | Khirurgiia 20090101 |
| Effect of the effluent released from the canine internal mammary artery after intraluminal and extraluminal perfusion of acetylcholine and adenosine diphosphate. | Journal of biomedical science 20090101 |
| Hook-up of GluA2, GRIP and liprin-alpha for cholinergic muscarinic receptor-dependent LTD in the hippocampus. | Molecular brain 20090101 |
| A novel mechanism of hippocampal LTD involving muscarinic receptor-triggered interactions between AMPARs, GRIP and liprin-alpha. | Molecular brain 20090101 |
| Illuminating the life of GPCRs. | Cell communication and signaling : CCS 20090101 |
| Operative treatment of transverse acetabular fractures: is it really necessary to fix both columns? | International journal of medical sciences 20090101 |
| Muscarinic acetylcholine receptor 1 gene polymorphisms associated with high myopia. | Molecular vision 20090101 |
| Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. | PloS one 20090101 |
| Presynaptic M1, M2, and A1 receptors play roles in tetanic fade induced by pancuronium or cisatracurium. | Journal of anesthesia 20090101 |
| Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands. | BMC pharmacology 20090101 |
| Bitopic ligands: all-in-one orthosteric and allosteric. | F1000 biology reports 20090101 |
| Characterization of Prejunctional Muscarinic Receptors: Effects on the Release of VIP and Functional Responses and Receptor Expression in the Ovine Submandibular Gland. | Advances in pharmacological sciences 20090101 |
| Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors. | European journal of pharmacology 20081203 |
| Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1. | Schizophrenia research 20081201 |
| Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake. | British journal of pharmacology 20081201 |
| Pharmacological properties, functional alterations and gene expression of muscarinic receptors in young and old type 2 Goto-Kakizaki diabetic rat bladders. | The Journal of urology 20081201 |
| The spinal muscarinic M(1) receptors and GABA(A) receptors contribute to the McN-A-343-induced antinociceptive effects during thermal stimulation of mice. | Journal of pharmacological sciences 20081201 |
| Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study. | Journal of ocular biology, diseases, and informatics 20081201 |
| cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. | Journal of medicinal chemistry 20081127 |
| Collective rotations of ferroelectric liquid crystals at the air/water interface. | Langmuir : the ACS journal of surfaces and colloids 20081104 |
| Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. | Molecular pharmacology 20081101 |
| Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin. | International journal of clinical practice 20081101 |
| Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol. | Journal of neural transmission (Vienna, Austria : 1996) 20081101 |
| Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine. | European journal of pharmacology 20081031 |
| Development of a homogeneous high-throughput live-cell G-protein-coupled receptor binding assay. | Journal of biomolecular screening 20080901 |
| Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation. | Neurobiology of learning and memory 20080901 |
| Role of muscarinic receptors in the activity of N-desmethylclozapine: reversal of hyperactivity in the phospholipase C knockout mouse. | Behavioural pharmacology 20080901 |
| Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20080801 |
| Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics. | Bioorganic & medicinal chemistry 20080801 |
| Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. | Journal of medicinal chemistry 20080724 |
| Asymmetrical distributions of muscarinic receptor binding in the hippocampus of female rats. | European journal of pharmacology 20080707 |
| Cholinergic modulation of neural activity in the telencephalon of the zebrafish. | Neuroscience letters 20080704 |
| Metabotropic receptor-activated calcium increases and store-operated calcium influx in mouse Müller cells. | Investigative ophthalmology & visual science 20080701 |
| Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat. | Archives of oral biology 20080701 |
| The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles. | Naunyn-Schmiedeberg's archives of pharmacology 20080701 |
| Muscarinic receptor M1 and phosphodiesterase 1 are key determinants in pulmonary vascular dysfunction following perinatal hypoxia in mice. | American journal of physiology. Lung cellular and molecular physiology 20080701 |
| Chronic treatment with simvastatin upregulates muscarinic M1/4 receptor binding in the rat brain. | Neuroscience 20080626 |
| Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20080611 |
| Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle. | Naunyn-Schmiedeberg's archives of pharmacology 20080601 |
| Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line. | American journal of physiology. Cell physiology 20080601 |
| Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor. | The Biochemical journal 20080515 |
| Effects of estrogen on intracellular signaling pathways linked to activation of muscarinic acetylcholine receptors and on acetylcholinesterase activity in rat hippocampus. | Biochemical pharmacology 20080501 |
| Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. | Scandinavian journal of gastroenterology 20080501 |
| Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. | Life sciences 20080423 |
| Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. | European journal of pharmacology 20080317 |
| Secretion of Streptomyces mobaraensis pro-transglutaminase by coryneform bacteria. | Applied microbiology and biotechnology 20080301 |
| The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink. | Neurotoxicology 20080301 |
| Cholinergic regulation of orexin/hypocretin neurons through M(3) muscarinic receptor in mice. | Journal of pharmacological sciences 20080301 |
| [Adjunctive therapies to glycaemic control of type 1 diabetes mellitus]. | Arquivos brasileiros de endocrinologia e metabologia 20080301 |
| Subtype-selective blockade of cardiac muscarinic receptors inhibits vagal chronotropic responses in cats. | Pflugers Archiv : European journal of physiology 20080201 |
| Changes in muscarinic receptors in the toad urothelial cell line TBM-54 following acrolein treatment. | Clinical and experimental pharmacology & physiology 20080201 |
| Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons. | Cellular and molecular neurobiology 20080201 |
| Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists. | Bioorganic & medicinal chemistry letters 20080201 |
| Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. | The European journal of neuroscience 20080201 |
| Functional expression of M3, a muscarinic acetylcholine receptor subtype, in taste bud cells of mouse fungiform papillae. | Chemical senses 20080101 |
| Actions of two main metabolites of propiverine (M-1 and M-2) on voltage-dependent L-type Ca2+ currents and Ca2+ transients in murine urinary bladder myocytes. | The Journal of pharmacology and experimental therapeutics 20080101 |
| Ability of cyclohexenonic long-chain fatty alcohol to ameliorate diabetes-induced cystopathy in the rat. | Pharmacology 20080101 |
| Distribution of adenosine receptors in human sclera fibroblasts. | Molecular vision 20080101 |
| Modulation of long-term potentiation by individual subtypes of muscarinic acetylcholine receptor in the rat dentate gyrus. | Hippocampus 20080101 |
| [Muscarinic acetylcholine receptors of the chick amnion]. | Izvestiia Akademii nauk. Seriia biologicheskaia 20080101 |
| Bitter taste receptors influence glucose homeostasis. | PloS one 20080101 |
| Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format. | Current chemical genomics 20080101 |
| Improvements in live cell analysis of G protein coupled receptors using second generation BD calcium assay kits. | Current chemical genomics 20080101 |
| Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes. | Bioorganic & medicinal chemistry 20071215 |
| Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis. | International immunopharmacology 20071205 |
| Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats. | Pharmacology, biochemistry, and behavior 20071001 |
| Ocular permeability of pirenzepine hydrochloride enhanced by methoxy poly(ethylene glycol)-poly(D, L-lactide) block copolymer. | Drug development and industrial pharmacy 20071001 |
| Calcium mobilization by activation of M(3)/M(5) muscarinic receptors in the human retinoblastoma. | Journal of pharmacological sciences 20071001 |
| The time course of transmitter release in mouse motor nerve terminals is differentially affected by activation of muscarinic M1 or M2 receptors. | The European journal of neuroscience 20071001 |
| N-hexacosanol prevents diabetes-induced rat ileal dysfunction without qualitative alteration of the muscarinic receptor system. | Biomedical research (Tokyo, Japan) 20071001 |
| Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease. | Neurobiology of aging 20070901 |
| Muscarinic M1 acetylcholine receptors regulate the non-quantal release of acetylcholine in the rat neuromuscular junction via NO-dependent mechanism. | Journal of neurochemistry 20070901 |
| Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901 |
| Allosteric modulation of muscarinic acetylcholine receptors. | Current neuropharmacology 20070901 |
| Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy. | Movement disorders : official journal of the Movement Disorder Society 20070815 |
| Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction. | European urology 20070801 |
| Vitamin A deficiency increases airway resistance following C-fiber stimulation. | Respiratory physiology & neurobiology 20070801 |
| Antagonism of nucleus accumbens M(2) muscarinic receptors disrupts operant responding for sucrose under a progressive ratio reinforcement schedule. | Behavioural brain research 20070719 |
| Muscarinic M2 receptor inhibition of calcium current in rat nucleus tractus solitarius. | Neuroreport 20070716 |
| Beneficial effect of preconditioning on ischemia-reperfusion injury in the rat bladder in vivo. | Life sciences 20070712 |
| Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. | Journal of neurochemistry 20070701 |
| Roles of muscarinic receptor subtypes in small intestinal motor dysfunction in acute radiation enteritis. | American journal of physiology. Gastrointestinal and liver physiology 20070701 |
| Expression and function of muscarinic receptor subtypes on human cornea and conjunctiva. | Investigative ophthalmology & visual science 20070701 |
| Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15. | The Journal of pharmacology and experimental therapeutics 20070601 |
| QSAR study on permeability of hydrophobic compounds with artificial membranes. | Bioorganic & medicinal chemistry 20070601 |
| Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia. | Biological psychiatry 20070515 |
| Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats. | Progress in neuro-psychopharmacology & biological psychiatry 20070509 |
| Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice. | Psychopharmacology 20070501 |
| Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment. | Journal of neuroscience research 20070501 |
| M1 muscarinic receptor modulation of Kir2 channels enhances temporal summation of excitatory synaptic potentials in prefrontal cortex pyramidal neurons. | Journal of neurophysiology 20070501 |
| Muscarinic receptor-independent activation of cyclic adenosine monophosphate-dependent protein kinase in rostral ventrolateral medulla underlies the sympathoexcitatory phase of cardiovascular responses during mevinphos intoxication in the rat. | Shock (Augusta, Ga.) 20070501 |
| Cardiovascular effects of carbachol microinjected into the bed nucleus of the stria terminalis of the rat brain. | Brain research 20070427 |
| Paradoxical effect of salbutamol in a model of acute organophosphates intoxication in guinea pigs: role of substance P release. | American journal of physiology. Lung cellular and molecular physiology 20070401 |
| Corticotropin-releasing factor inhibition of sheep fetal colonic contractility: mechanisms to prevent meconium passage in utero. | American journal of obstetrics and gynecology 20070401 |
| Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists. | Journal of agricultural and food chemistry 20070321 |
| Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors. | Neurochemical research 20070301 |
| In vitro effects of bethanechol on specimens of intestinal smooth muscle obtained from the duodenum and jejunum of healthy dairy cows. | American journal of veterinary research 20070301 |
| Activation of hippocampal postsynaptic muscarinic receptors is involved in long-term spatial memory formation. | The European journal of neuroscience 20070301 |
| Aging-induced decrease of cholinergic response and calcium sensitivity on rat jejunum contractions. | The journals of gerontology. Series A, Biological sciences and medical sciences 20070301 |
| Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum. | Journal of neuroscience research 20070215 |
| Dual-level afferent control of growth hormone-releasing hormone (GHRH) neurons in GHRH-green fluorescent protein transgenic mice. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070214 |
| Signaling pathways involved in pilocarpine-induced mucin secretion in rat submandibular glands. | Life sciences 20070206 |
| Muscarinic type 1 receptors mediate part of nitric oxide's vagal facilitatory effect in the isolated innervated rat right atrium. | Nitric oxide : biology and chemistry 20070201 |
| Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract. | Veterinary research communications 20070201 |
| In vitro characterization of parasympathetic and sympathetic responses in cyclophosphamide-induced cystitis in the rat. | Basic & clinical pharmacology & toxicology 20070201 |
| Nitric oxide and prostacyclin-dependent pathways involvement on in vitro induced hypothermia. | Cryobiology 20070201 |
| Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20070130 |
| Functional roles of muscarinic M2 and M3 receptors in mouse stomach motility: studies with muscarinic receptor knockout mice. | European journal of pharmacology 20070112 |
| Muscarinic receptor subtypes mediating positive and negative inotropy in the developing chick ventricle. | Journal of pharmacological sciences 20070101 |
| Phasic cholinergic signaling in the hippocampus: functional homology with the neocortex? | Hippocampus 20070101 |
| [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors]. | Klinicheskaia meditsina 20070101 |
| [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| Messenger RNA levels and binding sites of muscarinic acetylcholine receptors in gastrointestinal muscle layers from healthy dairy cows. | Journal of receptor and signal transduction research 20070101 |
| A genome-wide approach to identify the genes involved in biofilm formation in E. coli. | DNA research : an international journal for rapid publication of reports on genes and genomes 20070101 |
| Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats. | Brain research 20061206 |
| Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. | American journal of respiratory cell and molecular biology 20061201 |
| Molecular pharmacological approach to drug actions on the afferent and efferent fibres of the vagal nerve involved in gastric mucosal protection in rats. | Inflammopharmacology 20061201 |
| Serum levels of olanzapine and its N-desmethyl and 2-hydroxymethyl metabolites in child and adolescent psychiatric disorders: effects of dose, diagnosis, age, sex, smoking, and comedication. | Therapeutic drug monitoring 20061201 |
| Kinetic and molecular evidences that human cardiac muscle express non-M2 muscarinic receptor subtypes that are able to interact themselves. | Pharmacological research 20061101 |
| M3 muscarinic receptor-deficient mice retain bethanechol-mediated intestinal ion transport and are more sensitive to colitis. | Canadian journal of physiology and pharmacology 20061101 |
| Muscarinic regulation of neonatal rat bladder spontaneous contractions. | American journal of physiology. Regulatory, integrative and comparative physiology 20061001 |
| Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. | Neurobiology of aging 20060901 |
| Intrathecal clonidine suppresses zymosan-induced peripheral leukocyte migration in a mouse air pouch model via activation of spinal muscarinic type 2 receptors and sympathoadrenal medullary activity. | Neuropharmacology 20060901 |
| Selective blockade of central m1 muscarinic cholinergic receptors with pirenzepine impairs cardiovascular and respiratory function in rats with acute hemorrhage. | Bulletin of experimental biology and medicine 20060901 |
| CCCP enhances catecholamine release from the perfused rat adrenal medulla. | Autonomic neuroscience : basic & clinical 20060730 |
| Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors. | Autonomic & autacoid pharmacology 20060701 |
| Agonist and antagonist sensitivity of non-selective cation channel currents evoked by muscarinic receptor stimulation in bovine ciliary muscle cells. | Autonomic & autacoid pharmacology 20060701 |
| Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells. | Autonomic & autacoid pharmacology 20060701 |
| Muscarinic receptor subtypes modulate the release of [3H]-noradrenaline in rat spinal cord slices. | Brain research bulletin 20060615 |
| A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: evidence for differential inverse agonism. | The Journal of pharmacology and experimental therapeutics 20060601 |
| Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. | Neuropharmacology 20060601 |
| [Corneal permeability of topically applied pirenzepine solution]. | [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20060601 |
| Cardiac activity and blood pressure in rats during selective blockade of various subtypes of muscarinic cholinoceptors. | Bulletin of experimental biology and medicine 20060601 |
| Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury. | British journal of pharmacology 20060501 |
| Phase winding in chiral liquid crystalline monolayers due to Lehmann effects. | Physical review letters 20060414 |
| Cholinergic modulation of synaptic transmission and postsynaptic excitability in the rat gracilis dorsal column nucleus. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060412 |
| Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland. | Journal of applied physiology (Bethesda, Md. : 1985) 20060401 |
| Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal. | The European journal of neuroscience 20060401 |
| M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices. | Neurochemical research 20060401 |
| Muscarinic acetylcholine receptor subtypes in the rat seminal vesicle. | Molecular and cellular endocrinology 20060309 |
| Effects of muscarinic antagonists on ZENK expression in the chicken retina. | Experimental eye research 20060301 |
| Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients. | Neuropharmacology 20060301 |
| Ester derivatives of tournefolic acid B attenuate N-methyl-D-aspartate-mediated excitotoxicity in rat cortical neurons. | Molecular pharmacology 20060301 |
| Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein. | British journal of pharmacology 20060301 |
| [Inhibition of ACh on the delayed rectifier-like potassium current in acutely isolated cerebral cortical neurons of rats]. | Sheng li xue bao : [Acta physiologica Sinica] 20060225 |
| Involvement of the transmitter systems of the neostriatum in automation of motor skills in dogs. | Neuroscience and behavioral physiology 20060201 |
| Simultaneous release of glutamate and acetylcholine from single magnocellular 'cholinergic' basal forebrain neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060201 |
| Cholinergic receptor subtypes in the olfactory bulbectomy model of depression. | Brain research bulletin 20060130 |
| Epithelial muscarinic M1 receptors contribute to carbachol-induced ion secretion in mouse colon. | European journal of pharmacology 20060120 |
| Expression and localization of muscarinic acetylcholine receptor subtypes in rat efferent ductules and epididymis. | Cell and tissue research 20060101 |
| Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor. | The Journal of pharmacology and experimental therapeutics 20060101 |
| Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist. | Molecular pharmacology 20060101 |
| Effects of pirenzepine on Dai-kenchu-to-induced elevation of the plasma neuropeptide levels in humans. | Biological & pharmaceutical bulletin 20060101 |
| Central muscarinic receptor subtypes regulating voiding in rats. | The Journal of urology 20060101 |
| Effects of atropine and pirenzepine on heart rate turbulence. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101 |
| [Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease]. | Terapevticheskii arkhiv 20060101 |
| [Effect of pirenzepine on form deprivation myopia in chicks and its possible mechanism]. | [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20060101 |
| Muscarinic receptor signaling in the pathophysiology of asthma and COPD. | Respiratory research 20060101 |
| Management of acute pancreatitis: current knowledge and future perspectives. | World journal of emergency surgery : WJES 20060101 |
| A cholinergic mechanism underlies persistent neural activity necessary for eye fixation. | Progress in brain research 20060101 |
| A rapid and versatile method to label receptor ligands using 'click' chemistry: Validation with the muscarinic M1 antagonist pirenzepine. | Bioconjugate chemistry 20060101 |
| Allosteric modulators and selective agonists of muscarinic receptors. | Journal of molecular neuroscience : MN 20060101 |
| N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands. | Bioorganic & medicinal chemistry letters 20051215 |
| Muscarinic modulations of neuronal anticholinesterase responses. | Chemico-biological interactions 20051215 |
| On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies. | Journal of medicinal chemistry 20051201 |
| In vitro effects of bethanechol on equine gastrointestinal contractility and functional characterization of involved muscarinic receptor subtypes. | Journal of veterinary pharmacology and therapeutics 20051201 |
| A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. | Schizophrenia research 20051115 |
| 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization. | Journal of medicinal chemistry 20051103 |
| Cholinergic inhibition of neocortical pyramidal neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20051102 |
| Decreased accumulation of glutelin types in rice grains constitutively expressing a sunflower seed albumin gene. | Phytochemistry 20051101 |
| Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats. | Autonomic neuroscience : basic & clinical 20051030 |
| Cooperative glutamatergic and cholinergic mechanisms generate short-term modifications of synaptic effectiveness in prepositus hypoglossi neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20051026 |
| Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems. | British journal of pharmacology 20051001 |
| Preventive effect of chotosan, a Kampo medicine, on transient ischemia-induced learning deficit is mediated by stimulation of muscarinic M1 but not nicotinic receptor. | Biological & pharmaceutical bulletin 20051001 |
| Acetylcholine stimulates cyclic ADP-ribose formation via M1 muscarinic receptors in rat superior cervical ganglion. | Biochemical and biophysical research communications 20050930 |
| Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia. | Journal of neuroscience research 20050915 |
| Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis. | Biochemical and biophysical research communications 20050909 |
| Idiopathic facial paralysis (Bell's palsy) in the immediate puerperium in a patient with mild preeclampsia: a case report. | Archives of gynecology and obstetrics 20050901 |
| Intrathecal neostigmine reduces the zymosan-induced inflammatory response in a mouse air pouch model via adrenomedullary activity: involvement of spinal muscarinic type 2 receptors. | Neuropharmacology 20050901 |
| HPLC determination of pirenzepine dihydrochloride in rabbit aqueous humor. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805 |
| Excitatory effect of M1 muscarinic acetylcholine receptor on automaticity of mouse heart. | Archives of pharmacal research 20050801 |
| The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons. | Brain research 20050712 |
| Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. | Pharmacology, biochemistry, and behavior 20050701 |
| Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat. | Histology and histopathology 20050701 |
| The effects of microinjection of the selective blocker of muscarinic M1 receptors pirenzepine into the neostriatum on the motor behavior of rats. | Neuroscience and behavioral physiology 20050701 |
| Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. | Behavioural brain research 20050620 |
| Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice. | American journal of physiology. Gastrointestinal and liver physiology 20050601 |
| Regional differences in cholinergic regulation of potassium current in feline esophageal circular smooth muscle. | American journal of physiology. Gastrointestinal and liver physiology 20050601 |
| A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain. | Journal of chemical neuroanatomy 20050601 |
| M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders. | Brain research bulletin 20050515 |
| 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study. | Neuroscience letters 20050513 |
| Effects of (+/-)-huprine Y and (+/-)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors. | Neuroscience letters 20050506 |
| Autonomic efferents affect intake of imbalanced amino acid diets by rats. | Pharmacology, biochemistry, and behavior 20050501 |
| Ketamine reduces cholinergic modulated GABA release from rat striatal slices. | Toxicology letters 20050428 |
| Effect of pirenzepine ophthalmic solution on form-deprivation myopia in the guinea pigs. | Chinese medical journal 20050405 |
| Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. | British journal of pharmacology 20050401 |
| Signal transduction underlying carbachol-induced PGE2 generation and cox-1 mRNA expression of rat brain. | Neuropharmacology 20050401 |
| A pentylenetetrazole-induced generalized seizure in early life enhances the efficacy of muscarinic receptor coupling to G-protein in hippocampus and neocortex of adult rat. | The European journal of neuroscience 20050401 |
| Correlations between neuronal nitric oxide synthase and muscarinic M3/M1 receptors in the rat retina. | Experimental eye research 20050301 |
| The involvement of central cholinergic system in (+)-matrine-induced antinociception in mice. | Pharmacology, biochemistry, and behavior 20050301 |
| Effects of AF-DX116 and other muscarinic receptor antagonists on orthostatic hypotension in autonomic imbalanced (SART-stressed) rats. | Journal of pharmacological sciences 20050301 |
| Expression of muscarinic acetylcholine receptors and choline acetyltransferase enzyme in cultured antennal sensory neurons and non-neural cells of the developing moth Manduca sexta. | Journal of neurobiology 20050215 |
| Fluoxetine disrupts the integration of anxiety and aversive memories. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050201 |
| Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor. | Neurobiology of aging 20050101 |
| One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. | Ophthalmology 20050101 |
| Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane. | Acta pharmacologica Sinica 20050101 |
| [Blood circulation and secretory function in the gastric mucosa during inhibition of M1-cholinergic receptors and L-Ca2+-channels]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20050101 |
| [Peripheral mechanisms of vagal sinus arrhythmia: a role of typical affiliation of cardiac M-cholinoreceptors]. | Patologicheskaia fiziologiia i eksperimental'naia terapiia 20050101 |
| Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. | Neuroscience 20050101 |
| Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice. | Breast cancer research : BCR 20050101 |
| [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings]. | Khirurgiia 20050101 |
| [Fundamentals of modern treatment of myopia]. | Annales Academiae Medicae Stetinensis 20050101 |
| Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action. | Life sciences 20041203 |
| Potentiation of the osmosensitive release of taurine and D-aspartate from SH-SY5Y neuroblastoma cells after activation of M3 muscarinic cholinergic receptors. | The Journal of pharmacology and experimental therapeutics 20041201 |
| [Participation of the neostriatum transmission system in automation of motor skills in dogs]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20041201 |
| Characterization of functional effects of Z-338, a novel gastroprokinetic agent, on the muscarinic M1, M2, and M3 receptors expressed in Xenopus oocytes. | European journal of pharmacology 20041128 |
| Intrathecal clonidine inhibits mechanical allodynia via activation of the spinal muscarinic M1 receptor in streptozotocin-induced diabetic mice. | European journal of pharmacology 20041128 |
| The spinal muscarinic receptor subtypes contribute to the morphine-induced antinociceptive effects in thermal stimulation in mice. | Neuroscience letters 20041123 |
| Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats. | World journal of gastroenterology 20041115 |
| Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in micro-opioid receptor knockout mice. | Synapse (New York, N.Y.) 20041101 |
| Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study. | Archives of ophthalmology (Chicago, Ill. : 1960) 20041101 |
| The effects on place cells of local scopolamine dialysis are mimicked by a mixture of two specific muscarinic antagonists. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20041020 |
| Muscarinic antagonist control of myopia: a molecular search for the M1 receptor in chick. | Molecular vision 20041013 |
| Cholinergic regulation of the evoked quantal release at frog neuromuscular junction. | The Journal of physiology 20041001 |
| 3H-Noradrenaline release from mouse iris-ciliary body: role of presynaptic muscarinic heteroreceptors. | Naunyn-Schmiedeberg's archives of pharmacology 20041001 |
| Effects of pirenzepine on pupil size and accommodation in rhesus monkeys. | Investigative ophthalmology & visual science 20041001 |
| Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action. | General and comparative endocrinology 20041001 |
| Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning. | Behavioural brain research 20040923 |
| A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine. | Journal of pharmaceutical and biomedical analysis 20040903 |
| Prochlorperazine induces central antinociception mediated by the muscarinic system. | Pharmacological research 20040901 |
| Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices. | Neuropharmacology 20040901 |
| Effects of muscarinic acetylcholine receptor activation on membrane currents and intracellular messengers in medium spiny neurones of the rat striatum. | The European journal of neuroscience 20040901 |
| Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study. | The European journal of neuroscience 20040901 |
| Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor. | Journal of medicinal chemistry 20040812 |
| Maternal exposure to nicotine and chlorpyrifos, alone and in combination, leads to persistently elevated expression of glial fibrillary acidic protein in the cerebellum of the offspring in late puberty. | Archives of toxicology 20040801 |
| M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040801 |
| Parameters of drug antagonism: re-examination of two modes of functional competitive drug antagonism on intraocular muscles. | The Journal of pharmacy and pharmacology 20040801 |
| Cholinergic modulation of baker's yeast cell phagocytosis by rat astrocytes. | Neuroscience letters 20040715 |
| Inhibitory effect of fentanyl on acetylcholine-induced relaxation in rat aorta. | Anesthesiology 20040701 |
| Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84. | Journal of medicinal chemistry 20040603 |
| A specific synaptic pathway activates a conditional plateau potential underlying protraction phase in the Aplysia feeding central pattern generator. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040602 |
| Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats. | Neuropharmacology 20040601 |
| The effect of posterior hypothalamic injection of cholinergic agents on hippocampal formation theta in freely moving cat. | Brain research bulletin 20040530 |
| Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice. | European journal of pharmacology 20040525 |
| Acetylcholine regulates ghrelin secretion in humans. | The Journal of clinical endocrinology and metabolism 20040501 |
| Reduction of clozapine-induced hypersalivation by pirenzepine is safe. | Pharmacopsychiatry 20040301 |
| Contractile effect of acetylcholine on isolated isthmic segment of fallopian tubes. | Methods and findings in experimental and clinical pharmacology 20040301 |
| [Muscarinic receptors modulate the mRNA expression of NMDA receptors in brainstem and the release of glutamate in periaqueductal grey during morphine withdrawal in rats]. | Sheng li xue bao : [Acta physiologica Sinica] 20040225 |
| Modulation of muscarinic facilitation of epileptiform discharges in immature rat neocortex. | Brain research 20040206 |
| Profile of spinal and supra-spinal antinociception of (-)-linalool. | European journal of pharmacology 20040206 |
| [Effect of microinjections of a selective blocker of M1-muscarinic receptors pirenzepine into the neostriatum on the rat motor activity]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20040201 |
| Chlorpyrifos exposure during neurulation: cholinergic synaptic dysfunction and cellular alterations in brain regions at adolescence and adulthood. | Brain research. Developmental brain research 20040131 |
| High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. | Biological psychiatry 20040115 |
| A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040101 |
| Contractile effect of acetylcholine on isolated ampullar segment of Fallopian tubes. | Pharmacological research 20040101 |
| Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions. | Neuroscience 20040101 |
| An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies. | Journal of pharmacological and toxicological methods 20040101 |
| Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20040101 |
| Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. | Journal of the American Medical Directors Association 20040101 |
| Aging-related alterations in the contractile responses to acetylcholine, muscarinic cholinoceptors and cholinesterase activities in jejunum and colon of the male Fischer 344 rats. | Experimental gerontology 20040101 |
| M2 muscarinic receptors in pontine reticular formation of C57BL/6J mouse contribute to rapid eye movement sleep generation. | Neuroscience 20040101 |
| [Participation of the inhibitory mechanisms in the gastric hypersecretion caused by overproduction of glucocorticoids]. | Patologicheskaia fiziologiia i eksperimental'naia terapiia 20040101 |
| Activation of muscarinic acetylcholine receptors elicits pigment granule dispersion in retinal pigment epithelium isolated from bluegill. | BMC neuroscience 20040101 |
| Differential modulation by carbachol of four separate excitatory afferent systems to the rat subiculum in vitro. | Hippocampus 20040101 |
| Internet usage by low-literacy adults seeking health information: an observational analysis. | Journal of medical Internet research 20040101 |
| Potential adjunctive therapies in adolescents with type 1 diabetes mellitus. | Treatments in endocrinology 20040101 |
| Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels. | The Journal of physiology 20031215 |
| Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis. | Synapse (New York, N.Y.) 20031215 |
| Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes. | European journal of pharmacology 20031215 |
| Pulmonary embolism possibly associated with olanzapine treatment. | BMJ (Clinical research ed.) 20031213 |
| Chinese medicinal herbs Muh-Shiang Bin-Lang-Wan increases the motility of sphincter of Oddi in anesthetized rabbits through activation of M1 muscarinic receptors. | Life sciences 20031212 |
| Evidence of parasympathetic postganglionic neurons in the rat hypoglossal nerve trunk. | Experimental brain research 20031201 |
| Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats. | Neuropharmacology 20031201 |
| Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study. | Psychiatry and clinical neurosciences 20031201 |
| Rapid onset of dyskinesia induced by olanzapine. | Psychiatry and clinical neurosciences 20031201 |
| Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection. | Clinical chemistry 20031201 |
| Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia. | Therapeutic drug monitoring 20031201 |
| Pharmacologic management of psychosis in the elderly: a critical review. | Journal of geriatric psychiatry and neurology 20031201 |
| A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. | Archives of general psychiatry 20031201 |
| Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. | The Journal of clinical endocrinology and metabolism 20031201 |
| Impaired gastric secretion and lack of trophic responses to hypergastrinemia in M3 muscarinic receptor knockout mice. | Gastroenterology 20031201 |
| Olanzapine induces insulin resistance: results from a prospective study. | The Journal of clinical psychiatry 20031201 |
| Differential modulation of muscarinic receptors in the rat brain by repeated exposure to methyl parathion. | The Journal of toxicological sciences 20031201 |
| [Gastrozepin: is its oblivion fair?]. | Klinichna khirurhiia 20031201 |
| Simultaneous changes in secretory amyloid precursor protein and beta-amyloid peptide release from rat hippocampus by activation of muscarinic receptors. | Neuroscience letters 20031127 |
| Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. | JAMA 20031126 |
| Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031101 |
| Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats. | The Journal of pharmacology and experimental therapeutics 20031101 |
| Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031101 |
| Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats. | American journal of physical medicine & rehabilitation 20031101 |
| Olanzapine effects on auditory sensory gating in schizophrenia. | The American journal of psychiatry 20031101 |
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. | Archives of general psychiatry 20031101 |
| Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. | International journal of geriatric psychiatry 20031101 |
| Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study. | The Journal of clinical psychiatry 20031101 |
| [Neuroleptic malignant syndrome in a patient treated with olanzapine]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20031023 |
| Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex. | Neuroscience letters 20031009 |
| Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001 |
| Olanzapine in Chinese treatment-resistant patients with schizophrenia: an open-label, prospective trial. | Psychiatry and clinical neurosciences 20031001 |
| Schizophrenia, VI: Treatments. | The American journal of psychiatry 20031001 |
| Racial disparity in the use of atypical antipsychotic medications among veterans. | The American journal of psychiatry 20031001 |
| The effect of olanzapine on anxiety among patients with schizophrenia: preliminary findings. | Journal of clinical psychopharmacology 20031001 |
| Existence of functional M3-muscarinic receptors in the human heart. | Naunyn-Schmiedeberg's archives of pharmacology 20031001 |
| The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain. | Human psychopharmacology 20031001 |
| Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination. | Journal of the American Academy of Child and Adolescent Psychiatry 20031001 |
| Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031001 |
| Fungal dermatitis with olanzapine in schizophrenia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031001 |
| High-dose olanzapine and prolactin levels. | The Journal of clinical psychiatry 20031001 |
| Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial. | The Journal of clinical psychiatry 20031001 |
| Divalproex versus olanzapine in mania. | The Journal of clinical psychiatry 20031001 |
| Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. | Psychopharmacology 20030901 |
| Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. | Psychopharmacology 20030901 |
| Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment. | The Journal of pharmacology and experimental therapeutics 20030901 |
| Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. | Psychopharmacology 20030901 |
| Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. | Journal of neurochemistry 20030901 |
| Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders. | International clinical psychopharmacology 20030901 |
| Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study. | International clinical psychopharmacology 20030901 |
| Olanzapine and venous thromboembolism. | International clinical psychopharmacology 20030901 |
| Olanzapine for psychotic and behavioral disturbances in Alzheimer disease. | The Annals of pharmacotherapy 20030901 |
| Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine. | Bioorganic & medicinal chemistry 20030901 |
| Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. | International journal of geriatric psychiatry 20030901 |
| N-homolupinanoyl and N-(omega-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes. | Farmaco (Societa chimica italiana : 1989) 20030901 |
| Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years. | The Journal of clinical psychiatry 20030901 |
| Reducing the risk for suicide in schizophrenia and affective disorders. | The Journal of clinical psychiatry 20030901 |
| Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine. | The Journal of clinical psychiatry 20030901 |
| Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. | Biological psychiatry 20030815 |
| Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. | Biological psychiatry 20030815 |
| Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. | Psychopharmacology 20030801 |
| Bilateral lesions of the entorhinal cortex differentially modify haloperidol- and olanzapine-induced c-fos mRNA expression in the rat forebrain. | Neuropharmacology 20030801 |
| Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. | Journal of neuroscience research 20030801 |
| Muscarinic receptor subtypes mediate vasorelaxation in isolated horse deep dorsal penile vein. | Urology 20030801 |
| Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects. | British journal of clinical pharmacology 20030801 |
| Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. | The American journal of psychiatry 20030801 |
| Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. | The American journal of psychiatry 20030801 |
| Assessment of affinities and dissociation potencies of several 5-HT2 antagonists to and from M2 muscarinic receptor in rat heart membranes. | Biological & pharmaceutical bulletin 20030801 |
| Smooth muscle contraction induced by Indigofera dendroides leaf extracts may involve calcium mobilization via potential sensitive channels. | Phytotherapy research : PTR 20030801 |
| Antipsychotic-induced weight gain: bipolar disorder and leptin. | Journal of clinical psychopharmacology 20030801 |
| Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. | Journal of clinical psychopharmacology 20030801 |
| Olanzapine versus placebo in acute mania: treatment responses in subgroups. | Journal of clinical psychopharmacology 20030801 |
| A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine. | Journal of clinical psychopharmacology 20030801 |
| Potential use of olanzapine in treatment of substance dependence disorders. | Journal of clinical psychopharmacology 20030801 |
| Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine. | Pharmacotherapy 20030801 |
| Comparison of three antipsychotics in the emergency psychiatric setting. | Human psychopharmacology 20030801 |
| Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study. | Human psychopharmacology 20030801 |
| Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain. | Human psychopharmacology 20030801 |
| Eruptive xanthomas associated with olanzapine use. | Archives of dermatology 20030801 |
| An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. | The Journal of clinical psychiatry 20030801 |
| Olanzapine for cocaine cravings and relapse prevention. | The Journal of clinical psychiatry 20030801 |
| Olanzapine-associated bilateral pedal edema. | The Journal of clinical psychiatry 20030801 |
| Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands. | Journal of biomolecular screening 20030801 |
| Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030716 |
| [Type 2 diabetes and dyslipidemia. Side effects of 'Atypical' neuroleptics?]. | Medizinische Klinik (Munich, Germany : 1983) 20030715 |
| Deficits in avoidance responding after paradoxical sleep deprivation are not associated with altered [3H]pirenzepine binding to M1 muscarinic receptors in rat brain. | Brain research 20030704 |
| Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury. | Neurochemistry international 20030701 |
| Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats. | Psychoneuroendocrinology 20030701 |
| Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. | Schizophrenia research 20030701 |
| Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. | Endocrinology 20030701 |
| The combination of olanzapine and fluoxetine in mood disorders. | Expert opinion on pharmacotherapy 20030701 |
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. | The American journal of psychiatry 20030701 |
| Alpha2-adrenoceptor antagonism is neither sufficient nor necessary for the distinctive action of atypical neuroleptics on intracranial self-stimulation in the rat. | Behavioural pharmacology 20030701 |
| Olanzapine treatment of an adolescent girl with anorexia nervosa. | Human psychopharmacology 20030701 |
| [A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy]. | Der Nervenarzt 20030701 |
| [Life threatening neuroleptic malignant syndrome due to olanzapine]. | Psychiatrische Praxis 20030701 |
| A review of olanzapine-associated toxicity and fatality in overdose. | Journal of psychiatry & neuroscience : JPN 20030701 |
| Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects. | Journal of psychiatry & neuroscience : JPN 20030701 |
| Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. | The Journal of clinical psychiatry 20030701 |
| The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. | The Journal of clinical psychiatry 20030701 |
| Olanzapine/risperidone and diabetes risk. | The Journal of clinical psychiatry 20030701 |
| Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics. | The Journal of clinical psychiatry 20030701 |
| Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report. | The Journal of clinical psychiatry 20030701 |
| Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. | Southern medical journal 20030701 |
| Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine. | Southern medical journal 20030701 |
| Olanzapine and hypoglycemic coma in a frail elderly woman. A case report. | Pharmacopsychiatry 20030701 |
| Antipsychotic medication and seizures: a review. | Drugs of today (Barcelona, Spain : 1998) 20030701 |
| A pilot trial of olanzapine for the treatment of cocaine dependence. | Drug and alcohol dependence 20030605 |
| Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation. | The Journal of pharmacology and experimental therapeutics 20030601 |
| Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs. | Psychopharmacology 20030601 |
| Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. | Schizophrenia research 20030601 |
| Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity. | Journal of neuroscience research 20030601 |
| Olanzapine induced neuroleptic malignant syndrome--a case review. | Human psychopharmacology 20030601 |
| Treatment of cervical dystonia by olanzapine. | Human psychopharmacology 20030601 |
| Nonketotic hyperosmolar syndrome from olanzapine, lithium, and valproic acid cotreatment. | The Annals of pharmacotherapy 20030601 |
| Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. | Bipolar disorders 20030601 |
| Flushing and sweating in an advanced breast cancer patient relieved by olanzapine. | Journal of pain and symptom management 20030601 |
| Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. | Journal of pain and symptom management 20030601 |
| Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20030601 |
| Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalistic study. | Progress in neuro-psychopharmacology & biological psychiatry 20030601 |
| Use of atypical antipsychotic drugs in patients with dementia. | American family physician 20030601 |
| Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia. | The Journal of clinical psychiatry 20030601 |
| Chlorpromazine equivalent doses for the newer atypical antipsychotics. | The Journal of clinical psychiatry 20030601 |
| A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. | The Journal of clinical psychiatry 20030601 |
| Hypothermia in a hemodialysis patient treated with olanzapine monotherapy. | Journal of clinical psychopharmacology 20030601 |
| A tolerability study of pirenzepine ophthalmic gel in myopic children. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601 |
| On the mechanisms underlying histamine induction of gastric mucosal lesions in rats with partial gastric vascular occlusion. | Journal of pharmacological sciences 20030601 |
| QTc prolongation: chlorpromazine and high-dosage olanzapine. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601 |
| Should lipids be monitored during the first year of treatment with an atypical antipsychotic? | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601 |
| Potential risk of diabetes mellitus with the use of atypical antipsychotic medication. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601 |
| Treatment noncompliance with orally disintegrating olanzapine tablets. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601 |
| Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia. | The international journal of neuropsychopharmacology 20030601 |
| [Effects of pirenzepine on lens-induced myopia in the guinea-pig]. | [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20030601 |
| Atypical neuroleptics and diabetes. | Diabetes & metabolism 20030601 |
| [Rhabdomyolysis associated with respiratory infection in chronic psychiatric patients during neuroleptic treatment]. | Minerva anestesiologica 20030601 |
| [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression]. | MMW Fortschritte der Medizin 20030526 |
| [Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients]. | MMW Fortschritte der Medizin 20030526 |
| [Long-term therapy with intuition]. | MMW Fortschritte der Medizin 20030526 |
| Pharmacological approaches to the management of schizophrenia. | The Medical journal of Australia 20030505 |
| 6beta-acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain. | European journal of pharmacology 20030502 |
| Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030501 |
| The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. | Schizophrenia research 20030501 |
| The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the 'prodromal' sample. | Schizophrenia research 20030501 |
| Brain muscarinic receptor subtypes mediating water intake and Fos following cerebroventricular administration of bethanecol in rats. | Psychopharmacology 20030501 |
| Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. | Psychopharmacology 20030501 |
| Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients. | Progress in neuro-psychopharmacology & biological psychiatry 20030501 |
| The influence of olanzapine on immune cells in patients with schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20030501 |
| Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. | Journal of neurochemistry 20030501 |
| Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. | International clinical psychopharmacology 20030501 |
| The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting. | International clinical psychopharmacology 20030501 |
| Role of ethnicity in predicting antipsychotic medication adherence. | The Annals of pharmacotherapy 20030501 |
| Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetes. | Diabetes care 20030501 |
| Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. | Journal of cardiovascular pharmacology 20030501 |
| Cost evaluation of risperidone compared with olanzapine. | Psychiatric services (Washington, D.C.) 20030501 |
| Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia. | Journal of neural transmission (Vienna, Austria : 1996) 20030501 |
| A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. | Journal of pain and symptom management 20030501 |
| Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030501 |
| Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study. | Acta psychiatrica Scandinavica 20030501 |
| Olanzapine in the treatment-resistant, combat-related PTSD--a series of case reports. | Acta psychiatrica Scandinavica 20030501 |
| Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. | The Journal of clinical psychiatry 20030501 |
| Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis. | The Journal of clinical psychiatry 20030501 |
| Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. | The Journal of clinical psychiatry 20030501 |
| Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder. | The Journal of clinical psychiatry 20030501 |
| The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. | International journal of geriatric psychiatry 20030501 |
| Castration decreases amylase release associated with muscarinic acetylcholine receptor downregulation in rat parotid gland. | British journal of pharmacology 20030501 |
| Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease. | Managed care interface 20030501 |
| Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression. | Journal of psychiatry & neuroscience : JPN 20030501 |
| Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors. | Behavioural pharmacology 20030501 |
| A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. | Behavioural pharmacology 20030501 |
| Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine. | Behavioural pharmacology 20030501 |
| Calming versus sedative effects of intramuscular olanzapine in agitated patients. | The American journal of emergency medicine 20030501 |
| A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. | Clinical therapeutics 20030501 |
| [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. | Psychiatrische Praxis 20030501 |
| [Neuroleptics and cognition]. | Psychiatrische Praxis 20030501 |
| [3-D ultrasound-assisted gait analysis of schizophrenic patients. Comparison between conventional neuroleptics and olanzapine]. | Psychiatrische Praxis 20030501 |
| Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination. | Biochemical pharmacology 20030415 |
| Characterization of muscarinic receptor subtypes in the rostral ventrolateral medulla and effects on morphine-induced antinociception in rats. | European journal of pharmacology 20030404 |
| Economic evaluations of novel antipsychotic medications: a literature review. | Schizophrenia research 20030401 |
| Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. | American journal of physiology. Cell physiology 20030401 |
| The efficacy and safety of olanzapine for the treatment of geriatric psychosis. | Journal of clinical psychopharmacology 20030401 |
| Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. | Journal of clinical psychopharmacology 20030401 |
| Acute dysphoric mania: treatment response to olanzapine versus placebo. | Journal of clinical psychopharmacology 20030401 |
| Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. | Psychoneuroendocrinology 20030401 |
| Clinical trial response and dropout rates with olanzapine versus risperidone. | The Annals of pharmacotherapy 20030401 |
| Olanzapine and serotonin toxicity. | Psychiatry and clinical neurosciences 20030401 |
| Neuroleptic malignant syndrome and low-dose olanzapine. | The American journal of psychiatry 20030401 |
| Characterization of muscarinic autoreceptors in the rabbit hippocampus and caudate nucleus. | Neurochemical research 20030401 |
| Improving identification of treatment effectiveness in bipolar disorders. | Bipolar disorders 20030401 |
| Assessment of treatment response in mania: commentary and new findings. | Bipolar disorders 20030401 |
| Olanzapine elevation of serum creatine kinase. | The Journal of clinical psychiatry 20030401 |
| Effect of olanzapine on the liver transaminases. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030401 |
| Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. | Pharmacology, biochemistry, and behavior 20030401 |
| Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders. | Clinical therapeutics 20030401 |
| Olanzapine for intractable nausea in palliative care patients. | Journal of palliative medicine 20030401 |
| Report of three case studies with olanzapine for chronic pain. | The journal of pain : official journal of the American Pain Society 20030401 |
| The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion. | Life sciences 20030328 |
| Proliferative effect of acetylcholine on rat trachea epithelial cells is mediated by nicotinic receptors and muscarinic receptors of the M1-subtype. | Life sciences 20030328 |
| The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system. | Life sciences 20030328 |
| Nitric oxide (NO) synthase mRNA expression and NO production via muscarinic acetylcholine receptor-mediated pathways in the CEM, human leukemic T-cell line. | Life sciences 20030328 |
| Do atypical antipsychotics fail to exert cognitive sparing effects? | Neuroreport 20030303 |
| Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol. | Schizophrenia research 20030301 |
| The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment. | Acta psychiatrica Scandinavica 20030301 |
| The role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation. | Neurobiology of learning and memory 20030301 |
| Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. | Investigative ophthalmology & visual science 20030301 |
| Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated aceylcholine release from the rat minced pancreas in vitro. | European journal of biochemistry 20030301 |
| Olanzapine toxicity in unconjugated hyperbilirubinaemia (Gilbert's syndrome). | The British journal of psychiatry : the journal of mental science 20030301 |
| Comparative effectiveness of antipsychotic drugs. | The American journal of psychiatry 20030301 |
| Comparative effectiveness of antipsychotic drugs. | The American journal of psychiatry 20030301 |
| Comparative effectiveness of antipsychotic drugs. | The American journal of psychiatry 20030301 |
| Olanzapine treatment of anorexia nervosa: a retrospective study. | The International journal of eating disorders 20030301 |
| Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301 |
| Olanzapine and risperidone. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030301 |
| Psychosis associated with interferon alfa therapy for chronic hepatitis B. | The Annals of pharmacotherapy 20030301 |
| Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex. | Neuropharmacology 20030301 |
| Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. | Neuropharmacology 20030301 |
| Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030301 |
| Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride. | International journal of clinical practice 20030301 |
| The rebound excitation triggered by anticholinergic drugs from ovine pyloric antrum, small bowel and gallbladder. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20030301 |
| Treating acute mania. | The Journal of family practice 20030301 |
| Treating bipolar depression. | The Journal of family practice 20030301 |
| Long-term therapy of bipolar illness. | The Journal of family practice 20030301 |
| Optimal dosing of medications (in bipolar disorder). | The Journal of family practice 20030301 |
| Safety in treating bipolar disorder. | The Journal of family practice 20030301 |
| Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. | Journal of chemical neuroanatomy 20030301 |
| Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. | The Journal of clinical psychiatry 20030301 |
| A case report of olanzapine-induced fecal incontinence. | The Journal of clinical psychiatry 20030301 |
| Rehospitalization risk with second-generation and depot antipsychotics. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20030301 |
| Stressor-like effects of cocaine on heat shock protein and stress-activated protein kinase expression in the rat hippocampus: interaction with ethanol and anti-toxicity drugs. | Legal medicine (Tokyo, Japan) 20030301 |
| alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. | European journal of pharmacology 20030221 |
| Acute hepatocellular-cholestatic liver injury after olanzapine therapy. | Annals of internal medicine 20030218 |
| Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation. | Analytical biochemistry 20030215 |
| Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment. | The Australian and New Zealand journal of psychiatry 20030201 |
| M1 receptor-mediated nitric oxide-dependent relaxation unmasked in stomach fundus from M3 receptor knockout mice. | The Journal of pharmacology and experimental therapeutics 20030201 |
| A prospective, open-label trial of olanzapine in adolescents with schizophrenia. | Journal of the American Academy of Child and Adolescent Psychiatry 20030201 |
| Usefulness of olanzapine in refractory panic attacks. | Journal of clinical psychopharmacology 20030201 |
| Olanzapine induced 'typical' neuroleptic malignant syndrome. | Journal of clinical psychopharmacology 20030201 |
| Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication. | Therapeutic drug monitoring 20030201 |
| Treatment with the atypical antipsychotic, olanzapine, prevents the expression of amphetamine-induced place conditioning in the rat. | Progress in neuro-psychopharmacology & biological psychiatry 20030201 |
| Effects of olanzapine on auditory P300 in schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20030201 |
| Efficacy should drive atypical antipsychotic treatment. | BMJ (Clinical research ed.) 20030201 |
| Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. | The American journal of psychiatry 20030201 |
| Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. | The American journal of psychiatry 20030201 |
| Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. | The American journal of psychiatry 20030201 |
| Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice. | British journal of pharmacology 20030201 |
| [Koro--discussing a transcultural psychopathological phenomenon]. | Fortschritte der Neurologie-Psychiatrie 20030201 |
| Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy. | Pharmacotherapy 20030201 |
| Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia. | The Journal of clinical psychiatry 20030201 |
| Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention. | Brain and cognition 20030201 |
| Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. | Bipolar disorders 20030201 |
| Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients. | European archives of psychiatry and clinical neuroscience 20030201 |
| Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician. | Journal of the National Medical Association 20030201 |
| Effect of oxotremorine on resting membrane potential and cell volume in skeletal muscle fibers in rats after in vivo blockade of NO-synthase. | Bulletin of experimental biology and medicine 20030201 |
| Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia. | Wiener klinische Wochenschrift 20030131 |
| Cholinergic mechanism in the lateral septal area is involved in the stress-induced blood pressure increase in rats. | Brain research bulletin 20030130 |
| Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients. | Brain research 20030117 |
| Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity. | Biochemical pharmacology 20030115 |
| [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine]. | Nederlands tijdschrift voor geneeskunde 20030104 |
| New-onset diabetes and ketoacidosis with atypical antipsychotics. | Schizophrenia research 20030101 |
| An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. | Schizophrenia research 20030101 |
| PMA decreases the proliferation of retinal cells in vitro: the involvement of acetylcholine and BDNF. | Neurochemistry international 20030101 |
| Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports. | The International journal of eating disorders 20030101 |
| Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. | Journal of neuroscience research 20030101 |
| Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat. | Pharmacology, biochemistry, and behavior 20030101 |
| Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030101 |
| Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. | The Journal of pharmacology and experimental therapeutics 20030101 |
| Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol. | International clinical psychopharmacology 20030101 |
| Optimal dose of risperidone and olanzapine for patients with schizophrenia in Taiwan. | International clinical psychopharmacology 20030101 |
| Peripheral oedema in patients taking olanzapine. | International clinical psychopharmacology 20030101 |
| Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101 |
| Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101 |
| Valproic Acid and risperidone. | Journal of the American Academy of Child and Adolescent Psychiatry 20030101 |
| Olanzapine-associated seizure. | The Annals of pharmacotherapy 20030101 |
| Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. | Journal of affective disorders 20030101 |
| Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. | Journal of affective disorders 20030101 |
| Olanzepine-induced tardive dyskinesia. | The British journal of psychiatry : the journal of mental science 20030101 |
| Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). | Archives of general psychiatry 20030101 |
| Olanzapine and haloperidol: potential for neutropenia? | Psychosomatics 20030101 |
| Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. | Clinical endocrinology 20030101 |
| Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat. | The European journal of neuroscience 20030101 |
| Olanzapine efficacy in the treatment of essential tremor. | European journal of neurology 20030101 |
| Olanzapine for schizophrenia. | The Cochrane database of systematic reviews 20030101 |
| Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. | Journal of neural transmission (Vienna, Austria : 1996) 20030101 |
| Investigations of the cholinergic modulation of GABA release in rat thalamus slices. | Neuroscience 20030101 |
| An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. | The Journal of clinical psychiatry 20030101 |
| QTc prolongation and high-dose olanzapine. | Psychosomatics 20030101 |
| Olanzapine and quick-response hyperglycemia. | Psychosomatics 20030101 |
| Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. | Journal of sex & marital therapy 20030101 |
| New approaches to managing psychotic depression. | The Journal of clinical psychiatry 20030101 |
| Difficult-to-treat depressions: a primary care perspective. | The Journal of clinical psychiatry 20030101 |
| Cyclic ADP-ribose contributes to contraction and Ca2+ release by M1 muscarinic receptor activation in coronary arterial smooth muscle. | Journal of vascular research 20030101 |
| High-dose olanzapine for treatment-refractory schizophrenia. | Clinical neuropharmacology 20030101 |
| [Proposal for Latin America of an algorithm for the management of agitated patients with olanzapine and its switch to oral administration]. | Vertex (Buenos Aires, Argentina) 20030101 |
| Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. | The Journal of clinical psychiatry 20030101 |
| Acute dystonia caused by low dosage of olanzapine. | The Journal of neuropsychiatry and clinical neurosciences 20030101 |
| Heart transplantation and schizophrenia. | Psychosomatics 20030101 |
| Uncommon side effects associated with olanzapine. A case report. | Pharmacopsychiatry 20030101 |
| The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment. | Acta psychiatrica Scandinavica. Supplementum 20030101 |
| Are we nearsighted when it comes to myopia treatment? | Eye & contact lens 20030101 |
| Hyperglycemia from olanzapine treatment in adolescents. | Journal of child and adolescent psychopharmacology 20030101 |
| Assessing antipsychotic effectiveness in dementia with the factor structure of the Psychogeriatric Dependency Rating Scale (PGDRS). | Journal of the American Medical Directors Association 20030101 |
| Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients. | PharmacoEconomics 20030101 |
| Olanzapine-associated priapism. | Psychosomatics 20030101 |
| Olanzapine for corticosteroid-induced mood disorders. | Psychosomatics 20030101 |
| Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia. | Journal of the American Medical Directors Association 20030101 |
| The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients. | Journal of the American Medical Directors Association 20030101 |
| Fever, delirium, autonomic instability, and monocytosis associated with olanzapine. | Journal of postgraduate medicine 20030101 |
| [Protective effect of olanzapine in psychotic disorder induced by interferon-alpha]. | Recenti progressi in medicina 20030101 |
| [An introduction to antipsychotics]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Manic phase (manic episode)]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration]. | Vertex (Buenos Aires, Argentina) 20030101 |
| The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats. | Neuropsychobiology 20030101 |
| Involvement of cholinoceptors in cadmium-induced endothelial dysfunction. | Journal of basic and clinical physiology and pharmacology 20030101 |
| Quetiapine in the successful treatment of schizophrenia with comorbid alcohol and drug dependence: a case report. | International journal of psychiatry in medicine 20030101 |
| Olanzapine alone or in combination for acute mania. | The Cochrane database of systematic reviews 20030101 |
| Antipsychotic drugs and QT interval prolongation. | The Psychiatric quarterly 20030101 |
| Psoriasis during therapy with olanzapine. | European journal of dermatology : EJD 20030101 |
| Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV. | Psychosomatics 20030101 |
| Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients. | American journal of Alzheimer's disease and other dementias 20030101 |
| Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy. | American journal of therapeutics 20030101 |
| [Therapeutic options in manic states]. | L'Encephale 20030101 |
| Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury. | NeuroRehabilitation 20030101 |
| [Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial]. | Psychiatria polska 20030101 |
| The effects of an educational intervention on antipsychotic-induced weight gain. | Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing 20030101 |
| 5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia. | Psychopharmacology bulletin 20030101 |
| Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up. | Current medical research and opinion 20030101 |
| Tuberous sclerosis with psychosis. | Psychosomatics 20030101 |
| Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. | Schizophrenia bulletin 20030101 |
| [Demyelinating disease]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Brain tumor]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Porphyria]. | Ryoikibetsu shokogun shirizu 20030101 |
| Neurotransmitter relationships in the hypoxia-challenged cat carotid body. | Advances in experimental medicine and biology 20030101 |
| Optimal treatment project for schizophrenia: results from a randomized, controlled, longitudinal study. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20030101 |
| A 1-year open-label trial of olanzapine in school-age children with schizophrenia. | Journal of child and adolescent psychopharmacology 20030101 |
| Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study. | Journal of child and adolescent psychopharmacology 20030101 |
| Similarities and differences among antipsychotics. | The Journal of clinical psychiatry 20030101 |
| Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics. | Bipolar disorders 20030101 |
| Does the cholinergic system modulate gastrointestinal slow waves during less active phases of migrating myoelectric complex in healthy rams? | Folia medica Cracoviensia 20030101 |
| Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. | Brain research 20021220 |
| D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients. | Psychiatry research 20021215 |
| 'Normalization' of brain activation in schizophrenia. An fMRI study. | Schizophrenia research 20021201 |
| The intracellular pathway of the acetylcholine-induced contraction in cat detrusor muscle cells. | British journal of pharmacology 20021201 |
| The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts. | British journal of pharmacology 20021201 |
| Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain. | Nitric oxide : biology and chemistry 20021201 |
| Effects of development on olanzapine-associated adverse events. | Journal of the American Academy of Child and Adolescent Psychiatry 20021201 |
| Comparable dopamine 2 receptor occupancy. | The American journal of psychiatry 20021201 |
| Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study. | Journal of clinical psychopharmacology 20021201 |
| 5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia. | Journal of clinical psychopharmacology 20021201 |
| Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. | Psychopharmacology 20021201 |
| Pharmacotherapy of bipolar disorder: the role of atypical antipsychotics and experimental strategies. | Human psychopharmacology 20021201 |
| [Uncontrolled hyperglycemia with ketosis associated with olanzapine therapy]. | Revista clinica espanola 20021201 |
| Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment. | Clinical endocrinology 20021201 |
| The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021201 |
| Muscarinic and nicotinic presynaptic modulation of EPSCs in the nucleus accumbens during postnatal development. | Journal of neurophysiology 20021201 |
| Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia. | Journal of clinical pharmacy and therapeutics 20021201 |
| Sildenafil use in patients with olanzapine-induced erectile dysfunction. | International journal of impotence research 20021201 |
| Recent developments in pharmacotherapy for the acutely psychotic patient. | Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20021201 |
| Insight in persons with schizophrenia: effects of switching from conventional neuroleptics to atypical antipsychotics. | Progress in neuro-psychopharmacology & biological psychiatry 20021201 |
| Characterization of olanzapine-induced weight gain in rats. | Journal of psychopharmacology (Oxford, England) 20021201 |
| The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. | Journal of psychopharmacology (Oxford, England) 20021201 |
| Efficacy of olanzapine in social anxiety disorder: a pilot study. | Journal of psychopharmacology (Oxford, England) 20021201 |
| Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. | Journal of psychopharmacology (Oxford, England) 20021201 |
| Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats. | Neuropharmacology 20021201 |
| Influence of cytisine on catecholamine release in isolated perfused rat adrenal glands. | Archives of pharmacal research 20021201 |
| The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis. | The Journal of clinical psychiatry 20021201 |
| A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. | The Journal of clinical psychiatry 20021201 |
| An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. | The Journal of clinical psychiatry 20021201 |
| Olanzapine treatment for patients with schizophrenia and cocaine abuse. | The Journal of clinical psychiatry 20021201 |
| Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis. | Chemico-biological interactions 20021110 |
| Myopia: attempts to arrest progression. | The British journal of ophthalmology 20021101 |
| Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs. | International clinical psychopharmacology 20021101 |
| Weight gain associated with atypical antipsychotics. | Journal of the American Academy of Child and Adolescent Psychiatry 20021101 |
| Zebrafish M2 muscarinic acetylcholine receptor: cloning, pharmacological characterization, expression patterns and roles in embryonic bradycardia. | British journal of pharmacology 20021101 |
| An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. | Archives of general psychiatry 20021101 |
| [Mnestic impairment under olanzapine overdosage in an elderly patient]. | Psychiatrische Praxis 20021101 |
| Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. | The Journal of clinical psychiatry 20021101 |
| Olanzapine-induced hair loss. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021101 |
| Prescribing second-generation antipsychotics and the evolving standard of care in Italy. | Pharmacopsychiatry 20021101 |
| Olanzapine and improvement of tardive dyskinesia. | European psychiatry : the journal of the Association of European Psychiatrists 20021101 |
| Can olanzapine be implicated in causing serotonin syndrome? | Psychiatry and clinical neurosciences 20021001 |
| Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study. | Schizophrenia research 20021001 |
| Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol. | Schizophrenia research 20021001 |
| Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients. | Schizophrenia research 20021001 |
| Antagonistic effects of antimuscarinic drugs on alpha 1-adrenoceptors. | Naunyn-Schmiedeberg's archives of pharmacology 20021001 |
| Visual inspection of medications in preventing unexplained relapses. | The Annals of pharmacotherapy 20021001 |
| Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine. | Journal of clinical psychopharmacology 20021001 |
| Open-label study of olanzapine in children with pervasive developmental disorder. | Journal of clinical psychopharmacology 20021001 |
| Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects. | Journal of clinical psychopharmacology 20021001 |
| Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation. | Journal of clinical psychopharmacology 20021001 |
| Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study. | Journal of clinical psychopharmacology 20021001 |
| Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists and a nitric oxide synthase inhibitor. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20021001 |
| Norepinephrine in the treatment of olanzapine overdose. | Anaesthesia 20021001 |
| Muscarinic receptors in isolated urinary bladder smooth muscle from different mouse strains. | British journal of pharmacology 20021001 |
| Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. | The American journal of psychiatry 20021001 |
| [The role of olanzapine in Parkinsonian dopaminergic psychosis]. | Revista de neurologia 20021001 |
| Using antipsychotics in elderly patients. | The Practitioner 20021001 |
| The effects of novel antipsychotics on glucose and lipid levels. | The Journal of clinical psychiatry 20021001 |
| Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. | The Journal of clinical psychiatry 20021001 |
| Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. | The Journal of clinical psychiatry 20021001 |
| Severe hypertriglyceridemia associated with olanzapine. | The Journal of clinical psychiatry 20021001 |
| Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021001 |
| Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study. | Progress in neuro-psychopharmacology & biological psychiatry 20021001 |
| Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients. | Progress in neuro-psychopharmacology & biological psychiatry 20021001 |
| Use of atypical antipsychotics in a Veterans Affairs hospital. | Progress in neuro-psychopharmacology & biological psychiatry 20021001 |
| Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. | Bipolar disorders 20021001 |
| Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. | Autonomic neuroscience : basic & clinical 20020930 |
| Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. | International clinical psychopharmacology 20020901 |
| From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications. | The American journal of psychiatry 20020901 |
| Ziprasidone alternative for olanzapine-induced hyperglycemia. | The American journal of psychiatry 20020901 |
| Olanzapine in the treatment of anorexia nervosa: an open label trial. | The International journal of eating disorders 20020901 |
| [Improvement of tardive dyskinesia after treatment with olanzapine]. | Psychiatrische Praxis 20020901 |
| [Olanzapine-induced diabetes mellitus]. | Psychiatrische Praxis 20020901 |
| Continuum of care: stabilizing the acutely agitated patient. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020901 |
| Clinical issues associated with maintenance treatment of patients with schizophrenia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020901 |
| Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. | Journal of psychopharmacology (Oxford, England) 20020901 |
| Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. | Biological psychiatry 20020901 |
| [Regulatory mechanism of gastric acid secretion and mucosal integrity--an analysis with various gene deficient mice]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20020901 |
| Olanzapine-induced hyperventilation: case report. | Journal of psychiatry & neuroscience : JPN 20020901 |
| Atypical antipsychotics: experience and use in the elderly. | International journal of clinical practice 20020901 |
| Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain. | Journal of chemical neuroanatomy 20020901 |
| Olanzapine: a proarrhythmic drug? | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020901 |
| Olanzapine treatment for dopaminergic-induced hallucinations. | Movement disorders : official journal of the Movement Disorder Society 20020901 |
| Olanzapine excretion in human breast milk: estimation of infant exposure. | The international journal of neuropsychopharmacology 20020901 |
| Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment. | European psychiatry : the journal of the Association of European Psychiatrists 20020901 |
| [Olanzapine improves chorea in patients with Huntington's disease]. | Revista de neurologia 20020901 |
| [Zyprexa (olanzapine)--new possibilities in the treatment of schizophrenia]. | Voenno-meditsinskii zhurnal 20020901 |
| Presynaptic muscarinic receptor mechanisms and submandibular responses to stimulation of the parasympathetic innervation in bursts in rats. | Autonomic neuroscience : basic & clinical 20020830 |
| Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. | Psychiatry research 20020805 |
| [Treatment of tics in Tourette syndrome with atypical antipsychotic drugs]. | Ugeskrift for laeger 20020805 |
| Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. | BMJ (Clinical research ed.) 20020803 |
| Acetylcholine-induced phosphatidylinositol 4,5-bisphosphate depletion does not cause short-term desensitization of G protein-gated inwardly rectifying K+ current in mouse atrial myocytes. | The Journal of biological chemistry 20020802 |
| Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. | Brain : a journal of neurology 20020801 |
| Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication. | Therapeutic drug monitoring 20020801 |
| Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting. | Therapeutic drug monitoring 20020801 |
| Muscarinic effects of the Caribbean ciguatoxin C-CTX-1 on frog atrial heart muscle. | Toxicon : official journal of the International Society on Toxinology 20020801 |
| Lethal catatonia. | The Australian and New Zealand journal of psychiatry 20020801 |
| Emergence of compulsive symptoms with olanzapine treatment. | The Australian and New Zealand journal of psychiatry 20020801 |
| Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers. | Journal of clinical psychopharmacology 20020801 |
| Weight loss associated with olanzapine treatment. | Journal of clinical psychopharmacology 20020801 |
| Rapid onset of tardive dyskinesia in Huntington disease with olanzapine. | Journal of clinical psychopharmacology 20020801 |
| Characteristics and cholinergic control of the 'minute rhythm' in ovine antrum, small bowel and gallbladder. | Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20020801 |
| Possible involvement of M5 muscarinic receptor in the enhancing actions of the novel gastroprokinetic agent Z-338 on nifedipine-sensitive voltage-dependent Ca2+ currents in guinea pig stomach. | Japanese journal of pharmacology 20020801 |
| Restless legs syndrome and periodic limb movements of sleep: global therapeutic considerations. | Sleep medicine reviews 20020801 |
| [mRNA expression of muscarinic receptors in spinal cord and brainstem in morphine dependent rats]. | Yao xue xue bao = Acta pharmaceutica Sinica 20020801 |
| Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project. | Expert review of anticancer therapy 20020801 |
| Economic evaluations of olanzapine and risperidone. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020715 |
| Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine. | Pharmacology, biochemistry, and behavior 20020701 |
| Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020701 |
| Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. | Schizophrenia research 20020701 |
| Extreme weight gain in a youth with schizophrenia: risk/benefit considerations. | Schizophrenia research 20020701 |
| Olanzapine-associated type 2 diabetes mellitus. | Schizophrenia research 20020701 |
| Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine. | Psychiatric services (Washington, D.C.) 20020701 |
| One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics. | Psychiatric services (Washington, D.C.) 20020701 |
| Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. | Journal of neural transmission (Vienna, Austria : 1996) 20020701 |
| Atypical neuroleptics stimulate neurogenesis in adult rat brain. | Journal of neuroscience research 20020701 |
| Olanzapine-associated diabetes mellitus. | Pharmacotherapy 20020701 |
| Septal cholinergic mediation of hippocampal theta in the cat. | Brain research bulletin 20020701 |
| Effect of a single-dose of olanzapine on sleep in healthy females and males. | International clinical psychopharmacology 20020701 |
| Fatality from olanzapine induced hyperglycemia. | Journal of forensic sciences 20020701 |
| Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific. | The Journal of clinical psychiatry 20020701 |
| Olanzapine for cocaine craving and relapse prevention in 2 patients. | The Journal of clinical psychiatry 20020701 |
| Sleep-related eating disorder induced by olanzapine. | The Journal of clinical psychiatry 20020701 |
| The value of atypical antipsychotics in the treatment of schizophrenia. | Managed care (Langhorne, Pa.) 20020701 |
| Coexistence of Capgras and Frégoli syndromes in a single patient. Clinical, neuroimaging and neuropsychological findings. | European psychiatry : the journal of the Association of European Psychiatrists 20020701 |
| Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes. | Human psychopharmacology 20020701 |
| Olanzapine improves social dysfunction in cluster B personality disorder. | Human psychopharmacology 20020701 |
| Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. | The International journal of neuroscience 20020701 |
| Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020625 |
| Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain. | Neuroscience letters 20020607 |
| Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia. | Journal of clinical psychopharmacology 20020601 |
| Nitric oxide-cGMP-mediated vasoconstriction and effects of acetylcholine in the branchial circulation of the eel. | Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20020601 |
| Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. | Endocrinology 20020601 |
| Olanzapine in Huntington's disease. | Acta neurologica Scandinavica 20020601 |
| Prefrontal cortex acetylcholine release, EEG slow waves, and spindles are modulated by M2 autoreceptors in C57BL/6J mouse. | Journal of neurophysiology 20020601 |
| Olanzapine versus divalproex in the treatment of acute mania. | The American journal of psychiatry 20020601 |
| Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. | The American journal of psychiatry 20020601 |
| Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. | The American journal of psychiatry 20020601 |
| Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. | The American journal of psychiatry 20020601 |
| Quetiapine for olanzapine-induced galactorrhea. | The American journal of psychiatry 20020601 |
| Atypical antipsychotics and cognition in schizophrenia. | Archives of general psychiatry 20020601 |
| Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients. | Psychiatric services (Washington, D.C.) 20020601 |
| Y-931, a novel atypical antipsychotic drug, is less sensitive to oxidative phenomena. | Chemical & pharmaceutical bulletin 20020601 |
| Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. | The Journal of clinical endocrinology and metabolism 20020601 |
| Uses of olanzapine. | The Australian and New Zealand journal of psychiatry 20020601 |
| Ecstasy-induced psychotic disorder: six-month follow-up study. | European addiction research 20020601 |
| A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. | Journal of pain and symptom management 20020601 |
| Modulation by adenosine of both muscarinic M1-facilitation and M2-inhibition of [3H]-acetylcholine release from the rat motor nerve terminals. | The European journal of neuroscience 20020601 |
| A possible association between high normal and high dose olanzapine and prolongation of the PR interval. | Journal of psychopharmacology (Oxford, England) 20020601 |
| Influence of fluoxetine on olanzapine pharmacokinetics. | AAPS pharmSci 20020601 |
| A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia. | Psychopharmacology 20020601 |
| Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder. | Psychopharmacology 20020601 |
| Clozapine is more efficacious for tongue dystonia than olanzapine. | Psychopharmacology 20020601 |
| Olanzapine-induced galactorrhea. | Psychopharmacology 20020601 |
| Olanzapine in the treatment of refractory migraine and chronic daily headache. | Headache 20020601 |
| Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats. | Pharmacology, biochemistry, and behavior 20020601 |
| Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial. | The journal of ECT 20020601 |
| ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment. | The journal of ECT 20020601 |
| Olanzapine-associated neuroleptic malignant syndrome. | Progress in neuro-psychopharmacology & biological psychiatry 20020601 |
| A clinical case series of six extremely aggressive youths treated with olanzapine. | European child & adolescent psychiatry 20020601 |
| In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. | Life sciences 20020531 |
| Sex differences in clinical response to olanzapine compared with haloperidol. | Psychiatry research 20020515 |
| Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501 |
| Clinical and neuropsychological correlates of the P300 in schizophrenia. | Schizophrenia research 20020501 |
| Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine-induced gallbladder contractility. | The Journal of pharmacology and experimental therapeutics 20020501 |
| Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. | International clinical psychopharmacology 20020501 |
| A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. | Archives of general psychiatry 20020501 |
| Atypical neuroleptic malignant syndrome associated with olanzapine. | Pharmacotherapy 20020501 |
| Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. | The Journal of clinical psychiatry 20020501 |
| Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. | The Journal of clinical psychiatry 20020501 |
| A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. | The Journal of clinical psychiatry 20020501 |
| Phencyclidine supersensitivity in rats with neonatal dopamine loss. | Psychopharmacology 20020501 |
| Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. | Psychopharmacology 20020501 |
| Tardive dyskinesias and antipsychotics: a review. | European psychiatry : the journal of the Association of European Psychiatrists 20020501 |
| Olanzapine-induced mania in bipolar disorders. | Journal of psychiatry & neuroscience : JPN 20020501 |
| Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population. | Clinical therapeutics 20020501 |
| Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. | Journal of affective disorders 20020501 |
| Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine? | Pharmacopsychiatry 20020501 |
| Olanzapine and pregnancy. | Pharmacopsychiatry 20020501 |
| Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study. | Pharmacopsychiatry 20020501 |
| Olanzapine and progesterone have dose-dependent and additive effects to enhance lordosis and progestin concentrations of rats. | Physiology & behavior 20020501 |
| Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine. | Progress in neuro-psychopharmacology & biological psychiatry 20020501 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Decreased density of [3H]TCP binding following antipsychotic drug withdrawal in rats. | Life sciences 20020419 |
| Intrathecal alpha2 adrenoceptor agonist clonidine inhibits mechanical transmission in mouse spinal cord via activation of muscarinic M1 receptors. | Neuroscience letters 20020412 |
| Possible involvement of a muscarinic receptor in the anti-allodynic action of a 5-HT2 receptor agonist in rats with nerve ligation injury. | Brain research 20020405 |
| Acetylcholine-induced contractions in the perforating branch of the human internal mammary artery: protective role of the vascular endothelium. | Pharmacology 20020401 |
| The nature of the acetylcholine and 5-hydroxytryptamine receptors in buccal smooth muscle of the pest slug Deroceras reticulatum. | Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20020401 |
| Cholinergic regulation of the corpora allata in adult male loreyi leafworm Mythimna loreyi. | Archives of insect biochemistry and physiology 20020401 |
| Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. | The American journal of psychiatry 20020401 |
| Serotonin syndrome and atypical antipsychotics. | The American journal of psychiatry 20020401 |
| Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020401 |
| [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression]. | Fortschritte der Neurologie-Psychiatrie 20020401 |
| Weight gain and hyperglycaemia associated with olanzapine. | The Australian and New Zealand journal of psychiatry 20020401 |
| Effects of atypical antipsychotics on vertebrate neuromuscular transmission. | Neuropharmacology 20020401 |
| Lewy body dementia. | Journal of the Mississippi State Medical Association 20020401 |
| Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report. | International journal of geriatric psychiatry 20020401 |
| Olanzapine in the management of cancer pain. | Journal of pain and symptom management 20020401 |
| Motor-induced brain activation in cortical, subcortical and cerebellar regions in schizophrenic inpatients. A whole brain fMRI fingertapping study. | Progress in neuro-psychopharmacology & biological psychiatry 20020401 |
| The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital. | Progress in neuro-psychopharmacology & biological psychiatry 20020401 |
| [Delusional ectoparasitic infestation in multiple system atrophy]. | Der Nervenarzt 20020401 |
| Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland. | European journal of pharmacology 20020329 |
| Activation of muscarinic M1 receptors by acetylcholine to increase glucose uptake into cultured C2C12 cells. | Autonomic neuroscience : basic & clinical 20020318 |
| Muscarinic cholinergic receptor subtypes in the hippocampus of aged rats. | Mechanisms of ageing and development 20020315 |
| Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. | Biological psychiatry 20020315 |
| Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020301 |
| Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. | The American journal of psychiatry 20020301 |
| Olanzapine for violent schizophrenia and Klinefelter syndrome. | The American journal of psychiatry 20020301 |
| Effects of antipsychotic drugs on operant responding after acute and repeated administration. | Psychopharmacology 20020301 |
| [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients]. | Fortschritte der Neurologie-Psychiatrie 20020301 |
| Riluzole and olanzapine in Huntington's disease. | European journal of neurology 20020301 |
| Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. | Journal of the American Academy of Child and Adolescent Psychiatry 20020301 |
| Muscarinic receptors in human luteinized granulosa cells: activation blocks gap junctions and induces the transcription factor early growth response factor-1. | The Journal of clinical endocrinology and metabolism 20020301 |
| Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory. | Psychopharmacology 20020301 |
| Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics. | Psychopharmacology 20020301 |
| Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders. | International clinical psychopharmacology 20020301 |
| Olanzapine augmentation in the treatment of melancholia: the trajectory of improvement in rapid responders. | International clinical psychopharmacology 20020301 |
| High-dose olanzapine in Huntington's disease. | International clinical psychopharmacology 20020301 |
| New-onset seizure associated with quetiapine and olanzapine. | The Annals of pharmacotherapy 20020301 |
| New treatments in cluster headache. | Current neurology and neuroscience reports 20020301 |
| Eosinophilia associated with olanzapine. | The Journal of clinical psychiatry 20020301 |
| Olanzapine-induced destabilization of diabetes in the absence of weight gain. | Acta psychiatrica Scandinavica 20020301 |
| The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. | Journal of psychopharmacology (Oxford, England) 20020301 |
| Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat. | Journal of neural transmission (Vienna, Austria : 1996) 20020301 |
| [The effects of the antagonists of muscarinic acetylcholine receptor subtypes in rat brain on urinary bladder contraction]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20020301 |
| Muscarinic modulation of hypoxia-induced release of catecholamines from the cat carotid body. | Brain research 20020215 |
| Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020205 |
| Are the atypical antipsychotic drugs antidepressants? | Journal of clinical psychopharmacology 20020201 |
| Olanzapine-induced agranulocytosis: a case report and review of the literature. | Progress in neuro-psychopharmacology & biological psychiatry 20020201 |
| Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice. | Naunyn-Schmiedeberg's archives of pharmacology 20020201 |
| Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. | The American journal of psychiatry 20020201 |
| Use of dreams by psychopharmacologists. | The American journal of psychiatry 20020201 |
| Olanzapine in acute bipolar mania. | Archives of general psychiatry 20020201 |
| Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. | The Journal of clinical psychiatry 20020201 |
| Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis. | The Journal of clinical psychiatry 20020201 |
| A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia. | Managed care interface 20020201 |
| Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study. | Psychiatry and clinical neurosciences 20020201 |
| The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania. | Bipolar disorders 20020201 |
| Apraxia of eyelid closure in Huntington's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20020201 |
| Acute administration of antipsychotics modulates Homer striatal gene expression differentially. | Brain research. Molecular brain research 20020131 |
| [Drug-induced akathisia]. | Nederlands tijdschrift voor geneeskunde 20020119 |
| Muscarinic receptor subtypes mediate stimulatory and paradoxical inhibitory effects on an insulin-secreting beta cell line. | Biochimica et biophysica acta 20020115 |
| Role of mitogen-activated protein kinase pathway in acetylcholine-mediated in vitro relaxation of rat pulmonary artery. | European journal of pharmacology 20020102 |
| Coupling of M(2) muscarinic receptors to Src activation in cultured canine colonic smooth muscle cells. | American journal of physiology. Gastrointestinal and liver physiology 20020101 |
| Estrogen effects on object memory and cholinergic receptors in young and old female mice. | Neurobiology of aging 20020101 |
| Elevation of prolactin levels by atypical antipsychotics. | The American journal of psychiatry 20020101 |
| Increasing insulin dose for olanzapine-related diabetes. | The American journal of psychiatry 20020101 |
| Fluoxetine and olanzapine for resistant depression. | The American journal of psychiatry 20020101 |
| Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. | Archives of general psychiatry 20020101 |
| A correction. | Archives of general psychiatry 20020101 |
| Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis. | Pharmacotherapy 20020101 |
| Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication. | International clinical psychopharmacology 20020101 |
| Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine. | Journal of clinical pharmacology 20020101 |
| Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. | Pharmacology, biochemistry, and behavior 20020101 |
| The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers. | Clinical pharmacology and therapeutics 20020101 |
| [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease]. | Neurologia (Barcelona, Spain) 20020101 |
| Hyperinsulinemia in psychiatric patients treated with olanzapine. | The Journal of clinical psychiatry 20020101 |
| Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies. | Dementia and geriatric cognitive disorders 20020101 |
| Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism. | Experimental eye research 20020101 |
| Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. | Journal of psychiatric research 20020101 |
| The role of novel antipsychotics in bipolar disorders. | The Journal of clinical psychiatry 20020101 |
| Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. | The Journal of clinical psychiatry 20020101 |
| Movement disorders associated with atypical antipsychotic drugs. | The Journal of clinical psychiatry 20020101 |
| Significant dissociation of brain and plasma kinetics with antipsychotics. | Molecular psychiatry 20020101 |
| Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine. | Psychosomatics 20020101 |
| Psychiatric symptoms in a case of intracranial tuberculosis. | Psychosomatics 20020101 |
| [Gastrozepin therapy of gallbladder motility disorders in patients with ischemic heart disease]. | Likars'ka sprava 20020101 |
| Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. | CNS drugs 20020101 |
| Treatment of patients with tardive dystonia with olanzapine. | Clinical neuropharmacology 20020101 |
| The efficacy of olanzapine, as needed, to treat acute agitation in juveniles. | Journal of child and adolescent psychopharmacology 20020101 |
| Refractory obsessive-compulsive disorder: state-of-the-art treatment. | The Journal of clinical psychiatry 20020101 |
| Cardiovascular effects of novel antipsychotic medications. | Heart disease (Hagerstown, Md.) 20020101 |
| [Olanzapine in Tourette's syndrome: a report of three cases]. | Actas espanolas de psiquiatria 20020101 |
| [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region. | Schizophrenia bulletin 20020101 |
| Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. | The West Virginia medical journal 20020101 |
| The role of atypical antipsychotics in the treatment of delirium. | Psychosomatics 20020101 |
| An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. | Psychosomatics 20020101 |
| Masturbatory guilt leading to severe depression and erectile dysfunction. | Journal of sex & marital therapy 20020101 |
| Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. | The Annals of pharmacotherapy 20020101 |
| Direct-injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N-desmethylclozapine in human plasma. | Rapid communications in mass spectrometry : RCM 20020101 |
| Marked improvement of Meige's syndrome with olanzapine in a schizophrenic patient. | The Journal of neuropsychiatry and clinical neurosciences 20020101 |
| Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine. | Journal of child and adolescent psychopharmacology 20020101 |
| Near fatal ketoacidosis with olanzapine treatment. | Psychosomatics 20020101 |
| [Zyprexa with superior effectiveness-risk relation. For every therapy situation a suitable dosage form]. | Krankenpflege Journal 20020101 |
| [Muscarinic receptors of the neostriatum -- important targets of regulation of instrumental movement and posture]. | Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20020101 |
| Atypical antipsychotics in Parkinson-sensitive populations. | Journal of geriatric psychiatry and neurology 20020101 |
| Olanzapine-induced EDTA-dependent pseudothrombocytopenia. | Psychosomatics 20020101 |
| [Influence of serotonergic transmission on response to olanzapine]. | Actas espanolas de psiquiatria 20020101 |
| Olanzapine for Huntington's disease: an open label study. | Clinical neuropharmacology 20020101 |
| Effects of olanzapine and clozapine upon pulse rate variability. | Depression and anxiety 20020101 |
| Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study. | The Journal of neuropsychiatry and clinical neurosciences 20020101 |
| A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months. | Current medical research and opinion 20020101 |
| Olanzapine treatment of corticosteroid-induced mood disorders. | Psychosomatics 20020101 |
| Olanzapine and neuroleptic malignant syndrome. | Psychosomatics 20020101 |
| Glucose intolerance with atypical antipsychotics. | Drug safety 20020101 |
| Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia. | Molecular psychiatry 20020101 |
| Adverse drug reaction update. | Adverse drug reactions and toxicological reviews 20020101 |
| A cost-effectiveness clinical decision analysis model for treatment of Schizophrenia. | Archives of medical research 20020101 |
| [Schizoaffective disorder: clinical symptoms and present-day approach to treatment]. | Medicina (Kaunas, Lithuania) 20020101 |
| [RODOS: risperidone olanzapine drug outcome studies in schizophrenia]. | L'Encephale 20020101 |
| Olanzapine overdose: a pediatric case report. | Journal of child and adolescent psychopharmacology 20020101 |
| [Olanzapine in the first episode of schizophrenia in young adults]. | Psychiatria polska 20020101 |
| Comparing the side effect profile of the atypical antipsychotics. | West African journal of medicine 20020101 |
| [Effect of olanzapine treatment on cognitive functions in patients with schizophrenia]. | Psychiatria polska 20020101 |
| [Subjective and objective assessment of memory functions in patients with schizophrenia treated with olanzapine]. | Psychiatria polska 20020101 |
| Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications. | Schizophrenia bulletin 20020101 |
| M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse. | The Journal of pharmacology and experimental therapeutics 20011201 |
| Olanzapine-induced priapism. | The American journal of psychiatry 20011201 |
| Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. | Biological psychiatry 20011201 |
| Broad therapeutic uses of atypical antipsychotic medications. | Biological psychiatry 20011201 |
| The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease. | International journal of geriatric psychiatry 20011201 |
| A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data. | International journal of geriatric psychiatry 20011201 |
| Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia. | International journal of geriatric psychiatry 20011201 |
| Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. | International journal of geriatric psychiatry 20011201 |
| The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia. | Journal of clinical psychopharmacology 20011201 |
| Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study. | Journal of clinical psychopharmacology 20011201 |
| The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. | Journal of psychopharmacology (Oxford, England) 20011201 |
| Lethal catatonia responding to high-dose olanzapine therapy. | Journal of psychopharmacology (Oxford, England) 20011201 |
| Olanzapine treatment for patients with schizophrenia and substance abuse. | Journal of substance abuse treatment 20011201 |
| Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. | The Journal of clinical psychiatry 20011201 |
| Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose. | The Journal of clinical psychiatry 20011201 |
| Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20011201 |
| [Heart rate variability in schizophrenic patients treated with antipsychotic agents]. | Harefuah 20011201 |
| Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. | The Annals of pharmacotherapy 20011201 |
| Olanzapine-induced diabetic ketoacidosis. | The Annals of pharmacotherapy 20011201 |
| Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. | Journal of affective disorders 20011201 |
| Use of olanzapine for elderly patients with psychotic disorders: a review. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20011201 |
| Olanzapine and pregnancy. | The Australian and New Zealand journal of psychiatry 20011201 |
| Receptor binding studies of soft anticholinergic agents. | AAPS pharmSci 20011201 |
| Atypical antipsychotic drugs and hyperglycemia in adolescents. | JAMA 20011128 |
| Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates. | Journal of the American Chemical Society 20011107 |
| Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. | European journal of pharmacology 20011102 |
| Characterization of muscarinic acetylcholine receptor in rat Sertoli cells. | Endocrinology 20011101 |
| Global index of safety (GIS): a new instrument to assess drug safety. | Journal of clinical epidemiology 20011101 |
| Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. | Psychiatric services (Washington, D.C.) 20011101 |
| Conclusions about risperidone. | Psychiatric services (Washington, D.C.) 20011101 |
| Olanzapine augmentation for trichotillomania. | The American journal of psychiatry 20011101 |
| [Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring]. | Fortschritte der Neurologie-Psychiatrie 20011101 |
| Olanzapine treatment for post-traumatic stress disorder: an open-label study. | International clinical psychopharmacology 20011101 |
| Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine. | Psychopharmacology 20011101 |
| Dramatic worsening of type 2 diabetes mellitus due to olanzapine after 3 years of therapy. | Pharmacotherapy 20011101 |
| Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature. | Pharmacotherapy 20011101 |
| [Olanzapine and pregnancy. 2 case reports]. | Der Nervenarzt 20011101 |
| Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. | The Journal of clinical psychiatry 20011101 |
| Body weight gain, insulin, and leptin in olanzapine-treated patients. | The Journal of clinical psychiatry 20011101 |
| [Clinical and pharmacological studies of the second generation antipsychotics]. | Fukuoka igaku zasshi = Hukuoka acta medica 20011101 |
| Receptor reserve of phosphoinositide-coupled muscarinic receptors in mouse hippocampus in vivo. | Brain research 20011019 |
| On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder. | European journal of pharmacology 20011012 |
| Atypical antipsychotics: impaired glucose metabolism. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20011002 |
| An open pilot trial of olanzapine for delirium in the Korean population. | Psychiatry and clinical neurosciences 20011001 |
| The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011001 |
| Characterization of muscarinic acetylcholine receptors in the rat epididymis. | Biology of reproduction 20011001 |
| Use of olanzapine in dysphoric mania. | Journal of affective disorders 20011001 |
| Association of olanzapine-induced weight gain with an increase in body fat. | The American journal of psychiatry 20011001 |
| Agranulocytosis and neutropenia with typical and atypical neuroleptics. | The American journal of psychiatry 20011001 |
| Addition of olanzapine for treatment-resistant depression. | The American journal of psychiatry 20011001 |
| Forebrain muscarinic control of micturition reflex in rats. | Neuropharmacology 20011001 |
| Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. | Journal of clinical psychopharmacology 20011001 |
| Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. | Biological psychiatry 20011001 |
| Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine. | Psychopharmacology 20011001 |
| Olanzapine in pregnancy. | The Annals of pharmacotherapy 20011001 |
| P300 and symptom improvement in schizophrenia. | Psychopharmacology 20011001 |
| Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20011001 |
| Identification of muscarinic receptor subtypes of cultured smooth muscle cells and tissue of human bladder body. | International journal of urology : official journal of the Japanese Urological Association 20011001 |
| [Efficacy of rispolept and zyprexa in the treatment of patients with schizophrenia]. | Voenno-meditsinskii zhurnal 20011001 |
| [Diabetes mellitus induced by olanzapine. A case report]. | Revista medica de Chile 20011001 |
| Beneficial effect of muscarinic-2 antagonist on dilated cardiomyopathy induced by autoimmune mechanism against muscarinic-2 receptor. | Journal of cardiovascular pharmacology 20011001 |
| Service use and costs of treating schizophrenia with atypical antipsychotics. | The Journal of clinical psychiatry 20011001 |
| Olanzapine versus other antipsychotics in the treatment of schizophrenia. | The Journal of clinical psychiatry 20011001 |
| [Importance of blood glucose level when starting antipsychotic treatment]. | Presse medicale (Paris, France : 1983) 20010922 |
| Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. | European journal of pharmacology 20010907 |
| Integration of olanzapine determinations in a HPLC-diode array detection system for routine psychotropic drug monitoring. | Clinical chemistry 20010901 |
| Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database. | The American journal of psychiatry 20010901 |
| Muscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells. | The Journal of physiology 20010901 |
| Tissue distribution of olanzapine in a postmortem case. | The American journal of forensic medicine and pathology 20010901 |
| D2 receptor occupancy under recommended and high doses of olanzapine. | Journal of psychopharmacology (Oxford, England) 20010901 |
| [Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy]. | Der Nervenarzt 20010901 |
| Olanzapine-induced rhabdomyolysis. | The Annals of pharmacotherapy 20010901 |
| Olanzapine as an abortive agent for cluster headache. | Headache 20010901 |
| Re: Weight change with antipsychotic use. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010901 |
| Olanzapine induces remarkable weight gain in adolescent patients. | European child & adolescent psychiatry 20010901 |
| Are African American patients at a higher risk for olanzapine-induced glucose intolerance? | Psychopharmacology 20010901 |
| The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia. | The international journal of neuropsychopharmacology 20010901 |
| Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods. | The Journal of clinical psychiatry 20010901 |
| Treatment of preexisting diabetes with olanzapine. | The Journal of clinical psychiatry 20010901 |
| Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes. | European journal of clinical pharmacology 20010901 |
| An open trial of olanzapine in the treatment of patients with psychotic depression. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20010901 |
| Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. | Neurology 20010828 |
| Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. | Neurology 20010828 |
| Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint. | Psychiatry research 20010825 |
| Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. | European journal of pharmacology 20010817 |
| A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine. | Journal of chromatography. B, Biomedical sciences and applications 20010815 |
| Inhibition of myopia development in chicks using himbacine: a role for M(4) receptors? | Neuroreport 20010808 |
| Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography. | Journal of chromatography. B, Biomedical sciences and applications 20010805 |
| Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum. | Life sciences 20010803 |
| Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients. | Psychoneuroendocrinology 20010801 |
| Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010801 |
| Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan. | Psychiatry and clinical neurosciences 20010801 |
| Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial. | Psychiatry and clinical neurosciences 20010801 |
| Novel antipsychotics and severe hyperlipidemia. | Journal of clinical psychopharmacology 20010801 |
| Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America. | Journal of clinical psychopharmacology 20010801 |
| A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. | Journal of clinical psychopharmacology 20010801 |
| Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial. | Journal of clinical psychopharmacology 20010801 |
| Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service. | Therapeutic drug monitoring 20010801 |
| Instability of olanzapine in calf serum. | Therapeutic drug monitoring 20010801 |
| Pharmacological characterization of muscarinic receptors in mouse isolated urinary bladder smooth muscle. | British journal of pharmacology 20010801 |
| Olanzapine for the treatment of fibromyalgia symptoms. | Journal of pain and symptom management 20010801 |
| Mirtazapine for excessive masturbation in an adolescent with autism. | Journal of the American Academy of Child and Adolescent Psychiatry 20010801 |
| Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. | Journal of the American Academy of Child and Adolescent Psychiatry 20010801 |
| Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task. | Psychological medicine 20010801 |
| Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes. | Molecular and cellular neurosciences 20010801 |
| Muscarinic receptors control K+ secretion in inner ear strial marginal cells. | The Journal of membrane biology 20010801 |
| Tardive dystonia associated with olanzapine therapy. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010801 |
| ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. | Journal of medicinal chemistry 20010719 |
| Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. | Biological psychiatry 20010715 |
| Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. | The American journal of psychiatry 20010701 |
| Olanzapine-induced somnambulism. | The American journal of psychiatry 20010701 |
| A program for treating olanzapine-related weight gain. | Psychiatric services (Washington, D.C.) 20010701 |
| Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia. | Archives of general psychiatry 20010701 |
| Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study. | International clinical psychopharmacology 20010701 |
| Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study. | International clinical psychopharmacology 20010701 |
| Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. | International clinical psychopharmacology 20010701 |
| Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. | The Journal of clinical psychiatry 20010701 |
| Maternal obesity and risk of neural tube defects. | Canadian family physician Medecin de famille canadien 20010701 |
| Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats. | Psychopharmacology 20010701 |
| Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. | Psychopharmacology 20010701 |
| Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. | Psychopharmacology 20010701 |
| Use of atypical antipsychotics in mood disorders. | Current opinion in investigational drugs (London, England : 2000) 20010701 |
| Olanzapine for psychosis in Parkinson's disease. | Neurology 20010626 |
| Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. | The American journal of psychiatry 20010601 |
| Cognitive behavior therapy for weight gain. | The American journal of psychiatry 20010601 |
| Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report. | Journal of clinical psychopharmacology 20010601 |
| Hyperglycemia in patients with schizophrenia who are treated with olanzapine. | Journal of clinical psychopharmacology 20010601 |
| Antiaggressive action of atypical antipsychotics in patients with schizophrenia. | Journal of clinical psychopharmacology 20010601 |
| Sequence dependence of post-tetanic potentiation after sequential heterosynaptic stimulation in the rat auditory cortex. | The Journal of physiology 20010601 |
| Diabetic ketoacidosis associated with olanzapine in an adolescent patient. | The Journal of pediatrics 20010601 |
| Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine. | European psychiatry : the journal of the Association of European Psychiatrists 20010601 |
| Effects of cholinergic agents on the vasopressin-mediated water transport in the isolated toad bladder. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20010601 |
| Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach. | Journal of gastroenterology 20010601 |
| Does pirenzepine suppress the undesirable effects of a proton pump inhibitor on enterochromaffin-like cells? | Journal of gastroenterology 20010601 |
| The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia. | The Journal of nervous and mental disease 20010601 |
| Acute severe catatonia in a young woman with chronic schizophrenia responding to parenteral clonazepam. | The Australian and New Zealand journal of psychiatry 20010601 |
| Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach. | Clinical therapeutics 20010601 |
| Olanzapine-related hyperglycemia in a nondiabetic woman. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010601 |
| Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine. | Journal of psychopharmacology (Oxford, England) 20010601 |
| Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. | Psychopharmacology 20010601 |
| Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients. | The international journal of neuropsychopharmacology 20010601 |
| Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases. | European child & adolescent psychiatry 20010601 |
| Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome. | Endocrine journal 20010601 |
| Ziprasidone: a new atypical antipsychotic. | Expert opinion on pharmacotherapy 20010601 |
| Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol. | European archives of psychiatry and clinical neuroscience 20010601 |
| Antibodies against human putamen in adolescents with anorexia nervosa. | The International journal of eating disorders 20010501 |
| Agonist activation of cytosolic Ca2+ in subfornical organ cells projecting to the supraoptic nucleus. | American journal of physiology. Regulatory, integrative and comparative physiology 20010501 |
| Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. | The Journal of pharmacology and experimental therapeutics 20010501 |
| Molecular and pharmacological characterization of muscarinic receptor subtypes in a rat parotid gland cell line: comparison with native parotid gland. | The Journal of pharmacology and experimental therapeutics 20010501 |
| Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity. | The Journal of pharmacology and experimental therapeutics 20010501 |
| Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. | Molecular pharmacology 20010501 |
| Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla. | The Journal of experimental biology 20010501 |
| The antinociceptive and sedative effects of carbachol and oxycodone administered into brainstem pontine reticular formation and spinal subarachnoid space in rats. | Anesthesia and analgesia 20010501 |
| A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. | The American journal of psychiatry 20010501 |
| Olanzapine and negative and positive symptoms. | The American journal of psychiatry 20010501 |
| Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. | Psychiatric services (Washington, D.C.) 20010501 |
| Olanzapine-induced diabetes mellitus. | The Annals of pharmacotherapy 20010501 |
| Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010501 |
| Interaction of olanzapine with fluvoxamine. | Psychopharmacology 20010501 |
| Priapism associated with conventional and atypical antipsychotic medications: a review. | The Journal of clinical psychiatry 20010501 |
| Writer's cramp induced by olanzapine. | Journal of neurology 20010501 |
| [Analysis of olanzapine in human plasma with reversed-phase high performance liquid chromatography]. | Se pu = Chinese journal of chromatography 20010501 |
| Ligand characterization using microphysiometry. | Current protocols in neuroscience 20010501 |
| Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. | Schizophrenia research 20010430 |
| Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation. | Toxicon : official journal of the International Society on Toxinology 20010401 |
| Acetylcholine increases intracellular Ca2+ in the rat pituitary folliculostellate cells in primary culture. | American journal of physiology. Endocrinology and metabolism 20010401 |
| Ca(2+) signaling in porcine duodenal glands by muscarinic receptor activation. | American journal of physiology. Gastrointestinal and liver physiology 20010401 |
| Functional characterization of rat submaxillary gland muscarinic receptors using microphysiometry. | British journal of pharmacology 20010401 |
| Olanzapine and Huntington's disease. | Journal of clinical psychopharmacology 20010401 |
| Reply to comments on 'Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study'. | Journal of clinical psychopharmacology 20010401 |
| Olanzapine-associated priapism. | Journal of clinical psychopharmacology 20010401 |
| Acetylcholine increases the free intracellular calcium concentration in podocytes in intact rat glomeruli via muscarinic M(5) receptors. | Journal of the American Society of Nephrology : JASN 20010401 |
| Six-month outcomes for patients who switched to olanzapine treatment. | Psychiatric services (Washington, D.C.) 20010401 |
| Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic. | The American journal of psychiatry 20010401 |
| Ondansetron for tardive dyskinesia. | The American journal of psychiatry 20010401 |
| Olanzapine overdose. | Anaesthesia 20010401 |
| Comment: olanzapine-induced acute pancreatitis. | The Annals of pharmacotherapy 20010401 |
| Regulation of phospholipase Cbeta activity by muscarinic acetylcholine and 5-HT(2) receptors in crude and synaptosomal membranes from human cerebral cortex. | Neuropharmacology 20010401 |
| Manic symptoms induced by olanzapine. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401 |
| Effect of amantadine on weight gain during olanzapine treatment. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401 |
| Anticholinergic treatment improves glycaemic control in adolescent girls with insulin-dependent diabetes mellitus. | Acta paediatrica (Oslo, Norway : 1992) 20010401 |
| Use of olanzapine in non-psychotic psychiatric disorders. | Expert opinion on pharmacotherapy 20010401 |
| Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401 |
| Atypical antipsychotic drugs: how much better are they? | The Harvard mental health letter 20010401 |
| Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors. | The Journal of pharmacy and pharmacology 20010401 |
| Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine. | Progress in neuro-psychopharmacology & biological psychiatry 20010401 |
| Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. | Psychopharmacology 20010401 |
| Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice. | Psychopharmacology 20010401 |
| Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. | The Journal of clinical psychiatry 20010401 |
| Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. | The Journal of clinical psychiatry 20010401 |
| An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. | The Journal of clinical psychiatry 20010401 |
| Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder. | The Journal of clinical psychiatry 20010401 |
| Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. | The Journal of clinical psychiatry 20010401 |
| Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases. | The Journal of clinical psychiatry 20010401 |
| [Study on the muscarinic receptor and its subtypes in patients with chronic obstructive pulmonary disease]. | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20010401 |
| [What does olanzapine give us?]. | Atencion primaria 20010331 |
| The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria. | European journal of pharmacology 20010330 |
| Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. | Life sciences 20010309 |
| Separation of olanzapine, carbamazepine and their main metabolites by capillary electrophoresis with pseudo-stationary phases. | Journal of chromatography. B, Biomedical sciences and applications 20010305 |
| Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection. | Journal of chromatography. B, Biomedical sciences and applications 20010305 |
| Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. | The American journal of psychiatry 20010301 |
| Low blood glucose and olanzapine. | The American journal of psychiatry 20010301 |
| Dose-dependent olanzapine-associated leukopenia: three case reports. | International clinical psychopharmacology 20010301 |
| Atypical antipsychotics and hyperglycaemia. | International clinical psychopharmacology 20010301 |
| 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. | Journal of neurochemistry 20010301 |
| Autoantibodies against neonatal heart M1 muscarinic acetylcholine receptor in children with congenital heart block. | Journal of autoimmunity 20010301 |
| Serine/threonine protein phosphatases and synaptic inhibition regulate the expression of cholinergic-dependent plateau potentials. | Journal of neurophysiology 20010301 |
| Olanzapine-lnduced hyperglycemic nonketonic coma. | The Annals of pharmacotherapy 20010301 |
| Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. | Schizophrenia research 20010301 |
| Treatment of posttraumatic stress disorder with olanzapine. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010301 |
| Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. | Southern medical journal 20010301 |
| Dementia with Lewy bodies in Down's syndrome. | International journal of geriatric psychiatry 20010301 |
| Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. | The Journal of clinical psychiatry 20010301 |
| Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents. | Psychopharmacology 20010301 |
| Blood pressure and heart rate are increased by AF-DX 116, a selective M2 antagonist, in autonomic imbalanced and hypotensive rats caused by repeated cold stress. | Japanese journal of pharmacology 20010301 |
| Characterisation of the prejunctional inhibitory muscarinic receptor on cholinergic nerves in the rat urinary bladder. | European journal of pharmacology 20010216 |
| Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics. | The American journal of psychiatry 20010201 |
| Muscarinic receptor subtypes and calcium signaling in Fischer rat thyroid cells. | Biochemical pharmacology 20010201 |
| Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. | Archives of general psychiatry 20010201 |
| Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. | Synapse (New York, N.Y.) 20010201 |
| Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle. | British journal of pharmacology 20010201 |
| Atypical antipsychotics and cardiovascular risk in schizophrenic patients. | Journal of clinical psychopharmacology 20010201 |
| Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine. | Journal of clinical psychopharmacology 20010201 |
| The economic consequences of a drug-drug interaction. | Journal of clinical psychopharmacology 20010201 |
| Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial. | Journal of clinical psychopharmacology 20010201 |
| Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. | Journal of clinical psychopharmacology 20010201 |
| Fully automated on-line determination of olanzapine in serum for routine therapeutic drug monitoring. | Therapeutic drug monitoring 20010201 |
| Olanzapine and hypertriglyceridemia. | Journal of the American Academy of Child and Adolescent Psychiatry 20010201 |
| A case report of olanzapine-induced hypersensitivity syndrome. | The American journal of the medical sciences 20010201 |
| Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010201 |
| Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients. | International journal of geriatric psychiatry 20010201 |
| Priapism associated with polypharmacy. | The Journal of clinical psychiatry 20010201 |
| Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. | The Journal of clinical psychiatry 20010201 |
| [Anti-ulcer drug pirenzepin: new use as an aid for prevention of myopia?]. | Klinische Monatsblatter fur Augenheilkunde 20010201 |
| Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan). | The Australian and New Zealand journal of psychiatry 20010201 |
| Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture. | Neuroreport 20010122 |
| [Olanzapine and pregnancy]. | Orvosi hetilap 20010121 |
| Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. | Schizophrenia research 20010115 |
| A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure. | Journal of chromatography. B, Biomedical sciences and applications 20010105 |
| Effect of chronic olanzapine treatment on striatal synaptic organization. | Synapse (New York, N.Y.) 20010101 |
| Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands. | American journal of physiology. Lung cellular and molecular physiology 20010101 |
| Lowered seizure threshold on olanzapine. | The British journal of psychiatry : the journal of mental science 20010101 |
| Olanzapine: concordant response in monozygotic twins with schizophrenia. | The British journal of psychiatry : the journal of mental science 20010101 |
| A novel augmentation strategy for treating resistant major depression. | The American journal of psychiatry 20010101 |
| Misdiagnosis of schizophrenia for a patient with epilepsy. | Psychiatric services (Washington, D.C.) 20010101 |
| One further case of pancytopenia induced by olanzapine in a Parkinson's disease patient. | European neurology 20010101 |
| A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia. | Clinical and experimental pharmacology & physiology 20010101 |
| Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. | Annual review of medicine 20010101 |
| Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine. | Biological psychiatry 20010101 |
| Consistency of atypical antipsychotic superiority to placebo in recent clinical trials. | Biological psychiatry 20010101 |
| Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine. | Psychopharmacology 20010101 |
| Mechanisms of acetylcholine-induced vasorelaxation in high K+-stimulated rabbit renal arteries. | The Journal of veterinary medical science 20010101 |
| Olanzapine: an updated review of its use in the management of schizophrenia. | Drugs 20010101 |
| Bodyweight gain with atypical antipsychotics. A comparative review. | Drug safety 20010101 |
| Rapid tranquilization with olanzapine in acute psychosis: a case series. | The Journal of clinical psychiatry 20010101 |
| Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia. | The Journal of clinical psychiatry 20010101 |
| The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms. | The Journal of clinical psychiatry 20010101 |
| An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. | The Journal of clinical psychiatry 20010101 |
| Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone. | The Journal of clinical psychiatry 20010101 |
| Introduction: a new era in the pharmacotherapy of psychotic disorders. | The Journal of clinical psychiatry 20010101 |
| Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics. | The Journal of clinical psychiatry 20010101 |
| Weight change and atypical antipsychotic treatment in patients with schizophrenia. | The Journal of clinical psychiatry 20010101 |
| Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial. | The Journal of clinical psychiatry 20010101 |
| Short-term effects of olanzapine in Huntington disease. | Neuropsychiatry, neuropsychology, and behavioral neurology 20010101 |
| The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease. | The Journal of clinical psychiatry 20010101 |
| Olanzapine may be an effective adjunctive therapy in the management of acne excoriée: a case report. | Journal of cutaneous medicine and surgery 20010101 |
| First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression. | Neuropsychobiology 20010101 |
| [Viewpoint of schizophrenic patients: a European survey]. | L'Encephale 20010101 |
| Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report. | Clinical neuropharmacology 20010101 |
| Pharmacology, distribution and development of muscarinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens. | Neuroscience 20010101 |
| A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates. | Neurocase 20010101 |
| [Obsessive-compulsive disorders in adolescents with diagnosed schizophrenia]. | Psychiatria polska 20010101 |
| [Subjective and objective evaluation of treating schizophrenia with classic or atypical drugs]. | Psychiatria polska 20010101 |
| [Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: results of an observational study]. | Actas espanolas de psiquiatria 20010101 |
| [Olanzapine and cognitive-behavioural group therapy in borderline personality disorder]. | Actas espanolas de psiquiatria 20010101 |
| [Treatment of schizophrenia in subjects with substance use disorders: A review]. | Actas espanolas de psiquiatria 20010101 |
| Antipsychotic-induced weight gain: a review of the literature. | The Journal of clinical psychiatry 20010101 |
| The pharmacology of weight gain with antipsychotics. | The Journal of clinical psychiatry 20010101 |
| Priapism after a suicide attempt by ingestion of olanzapine and gabapentin. | Psychosomatics 20010101 |
| Hypothesis and hypothesis testing in the clinical trial. | The Journal of clinical psychiatry 20010101 |
| Olanzapine: another psychotropic? | The American journal of hospice & palliative care 20010101 |
| Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test. | Neuroscience 20010101 |
| Distinct muscarinic receptors enhance spontaneous GABA release and inhibit electrically evoked GABAergic synaptic transmission in the chick lateral spiriform nucleus. | Neuroscience 20010101 |
| Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature. | The Journal of the American Board of Family Practice 20010101 |
| Treatment with atypical antipsychotics: new indications and new populations. | Journal of psychiatric research 20010101 |
| [Olanzapine efficacy in the treatment of cocaine abuse in methadone maintenance patients. Interaction with plasma levels]. | Actas espanolas de psiquiatria 20010101 |
| Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101 |
| Olanzapine-induced respiratory failure. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101 |
| M1 receptor activation is a requirement for arecoline analgesia. | Farmaco (Societa chimica italiana : 1989) 20010101 |
| Olanzapine-lithium encephalopathy. | Psychosomatics 20010101 |
| Cholinergic nerves mediate acetaldehyde action in the gastrointestinal tract. | Alcohol and alcoholism (Oxford, Oxfordshire) 20010101 |
| Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence. | Current opinion in investigational drugs (London, England : 2000) 20010101 |
| Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. | BMC pharmacology 20010101 |
| New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study. | European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20010101 |
| Muscarinic receptor subtypes mediating vasorelaxation of the perforating branch of the human internal mammary artery. | Pharmacology 20010101 |
| Hyperglycemia associated with the use of atypical antipsychotics. | The Journal of clinical psychiatry 20010101 |
| Review of atypical antipsychotics and weight gain. | The Journal of clinical psychiatry 20010101 |
| A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. | Journal of child and adolescent psychopharmacology 20010101 |
| Hyperglycemia and hypertriglyceridemia secondary to olanzapine. | Journal of child and adolescent psychopharmacology 20010101 |
| Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report. | Therapie 20010101 |
| Olanzapine: a review of its use in the treatment of bipolar I disorder. | CNS drugs 20010101 |
| Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. | Neuroscience 20010101 |
| Slow synchronized bursts of inhibitory postsynaptic currents (0.1-0.3 Hz) by cholinergic stimulation in the rat frontal cortex in vitro. | Neuroscience 20010101 |
| Muscarinic receptors influence catecholamine release from the cat carotid body during hypoxia. | Advances in experimental medicine and biology 20010101 |
| National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101 |
| Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease. | The Journal of neuropsychiatry and clinical neurosciences 20010101 |
| Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia. | Psychosomatics 20010101 |
| Persistent psychosis after a single ingestion of 'ecstasy'. | Psychosomatics 20010101 |
| Olanzapine usage associated with neuroleptic malignant syndrome. | Psychosomatics 20010101 |
| Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study. | Schizophrenia bulletin 20010101 |
| [Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated with risperidone or olanzapine]. | Therapie 20010101 |
| Prevention of experimental autoimmune cardiomyopathy in rabbits by receptor blockers. | Autoimmunity 20010101 |
| Opposite effects of olanzapine and haloperidol in rat ultrasonic vocalization test. | Polish journal of pharmacology 20010101 |
| Cholinergic stimulation of rat acinar cells increases c-fos and c-jun expression via a mitogen-activated protein kinase-dependent pathway. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20010101 |
| The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. | Journal of autonomic pharmacology 20010101 |
| Neuroleptic malignant syndrome due to olanzapine. | Psychopharmacology bulletin 20010101 |
| Panic disorder associated with clozapine. | The American journal of psychiatry 20001201 |
| Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. | The Journal of emergency medicine 20001101 |
| Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. | Pharmacopsychiatry 20001101 |
| Risperidone and tardive dyskinesia: a case of blepharospasm. | The Australian and New Zealand journal of psychiatry 20001001 |
| Quetiapine for l-dopa-induced psychosis in PD. | Neurology 20000926 |
| Olanzapine and obsessive-compulsive symptoms. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20000901 |
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. | Archives of general psychiatry 20000901 |
| A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. | The Journal of clinical psychiatry 20000901 |
| The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. | Clinical therapeutics 20000901 |
| Esotropia associated with olanzapine. | Journal of clinical psychopharmacology 20000801 |
| Case report of withdrawal syndrome after olanzapine discontinuation. | Journal of clinical psychopharmacology 20000801 |
| Remission of tardive dyskinesia after changing from flupenthixol to olanzapine. | European psychiatry : the journal of the Association of European Psychiatrists 20000801 |
| Olanzapine-induced urinary incontinence: treatment with ephedrine. | The Journal of clinical psychiatry 20000801 |
| Olanzapine optimal dose: results of an open-label multicenter study in schizophrenic patients. Olanzapine Late-Phase II Study Group. | Psychiatry and clinical neurosciences 20000801 |
| Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. | Journal of clinical psychopharmacology 20000601 |
| Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia. | Journal of clinical psychopharmacology 20000601 |
| Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. | The American journal of psychiatry 20000601 |
| Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. | The American journal of psychiatry 20000601 |
| The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia. | The Journal of clinical psychiatry 20000501 |
| Possible neuroleptic malignant syndrome associated with olanzapine. | The Annals of pharmacotherapy 20000501 |
| Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina. | Clinical therapeutics 20000501 |
| Quetiapine for l-dopa-induced psychosis in PD. | Neurology 20000411 |
| Seizures caused by possible interaction between olanzapine and clomipramine. | Journal of clinical psychopharmacology 20000401 |
| [A case of mania following olanzapine administration]. | Psychiatria polska 20000101 |
| [Psychotic syndrome after withdrawal of cyproheptadine: remission with olanzapine]. | Actas espanolas de psiquiatria 20000101 |
| D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. | Journal of psychopharmacology (Oxford, England) 20000101 |
| Haloperidol-induced impotence improved by switching to olanzapine. | General hospital psychiatry 20000101 |
| Hypomania-like syndrome induced by olanzapine. | International clinical psychopharmacology 19991101 |
| Worsening of motor features of parkinsonism with olanzapine. | Movement disorders : official journal of the Movement Disorder Society 19991101 |
| Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics. | Methods and findings in experimental and clinical pharmacology 19991101 |
| Olanzapine-induced psychotic mania in bipolar schizo-affective disorder. | European psychiatry : the journal of the Association of European Psychiatrists 19991101 |
| Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. | Journal of clinical psychopharmacology 19991001 |
| Olanzapine-induced tardive dystonia. | The American journal of psychiatry 19991001 |
| Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. | European psychiatry : the journal of the Association of European Psychiatrists 19991001 |
| Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report. | Arquivos de neuro-psiquiatria 19990901 |
| In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study. | European journal of nuclear medicine 19990801 |
| Olanzapine-induced mania. | The American journal of psychiatry 19990701 |
| Interaction between olanzapine and haloperidol. | Journal of clinical psychopharmacology 19990601 |
| [Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon]. | Annales francaises d'anesthesie et de reanimation 19990601 |
| Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. | The American journal of psychiatry 19990501 |
| Olanzapine-induced obsessive-compulsive disorder. | The American journal of psychiatry 19990501 |
| In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine. | Psychiatry research 19990426 |
| Risperidone-induced tardive dystonia and psychosis. | Lancet (London, England) 19990320 |
| [Neuroleptic malignant syndrome after treatment with olanzapine]. | Ugeskrift for laeger 19990308 |
| Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine. | European journal of pharmacology 19990226 |
| Hyperprolactinemia and male sexual dysfunction. | The Journal of clinical psychiatry 19990201 |
| Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. | Schizophrenia research 19990104 |
| Olanzapine versus haloperidol treatment in first-episode psychosis. | The American journal of psychiatry 19990101 |
| Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats. | European journal of pharmacology 19990101 |
| M3 muscarinic receptor activation of a delayed rectifier potassium current in canine atrial myocytes. | Life sciences 19990101 |
| Use of olanzapine in hereditary coproporphyria. | Psychosomatics 19990101 |
| Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note. | Journal of neurology, neurosurgery, and psychiatry 19981101 |
| Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment. | Journal of psychiatry & neuroscience : JPN 19981101 |
| Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. | British journal of pharmacology 19981101 |
| Alleviation of sulpiride induced tardive akathisia by olanzapine: case report. | Neurologia (Barcelona, Spain) 19981101 |
| Olanzapine use in women with antipsychotic-induced hyperprolactinemia. | The American journal of psychiatry 19981001 |
| Isoniazid-induced psychosis. | The Annals of pharmacotherapy 19980901 |
| Conventional psychotropic-induced tremor extinguished by olanzapine. | The American journal of psychiatry 19980801 |
| Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. | The American journal of psychiatry 19980701 |
| Acute dystonia with olanzapine. | The Journal of clinical psychiatry 19980701 |
| Severe akathisia during olanzapine treatment of acute schizophrenia. | Pharmacopsychiatry 19980701 |
| Worsening of obsessive-compulsive symptoms following treatment with olanzapine. | The American journal of psychiatry 19980601 |
| Olanzapine-induced manic-like syndrome. | The Journal of clinical psychiatry 19980601 |
| Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. | The Journal of pharmacology and experimental therapeutics 19980201 |
| Mania associated with olanzapine. | Journal of the American Academy of Child and Adolescent Psychiatry 19980201 |
| The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine. | Psychopharmacology bulletin 19980101 |
| Priapism following olanzapine administration in a patient with multiple sclerosis. | Psychosomatics 19980101 |
| Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations. | The Journal of clinical psychiatry 19980101 |
| Olanzapine attenuates the reinforcing effects of cocaine. | European journal of pharmacology 19971204 |
| High-dose olanzapine for treatment-refractory schizophrenia. | The American journal of psychiatry 19971101 |
| Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia. | The Journal of clinical psychiatry 19971101 |
| Dopaminergic and cholinergic interaction in cataleptic responses in mice. | Pharmacology, biochemistry, and behavior 19970901 |
| Propranolol treatment of olanzapine-induced akathisia. | The American journal of psychiatry 19970901 |
| Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. | Diabetes 19970901 |
| Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness. | Psychopharmacology 19970801 |
| The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. | Schizophrenia research 19970725 |
| Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. | The Journal of clinical psychiatry 19970501 |
| Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. | The American journal of psychiatry 19970401 |
| Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. | British journal of pharmacology 19970401 |
| Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats. | Naunyn-Schmiedeberg's archives of pharmacology 19970301 |
| Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. | Psychopharmacology 19970201 |
| Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors. | Journal of receptor and signal transduction research 19970101 |
| Safety of olanzapine. | The Journal of clinical psychiatry 19970101 |
| Dosing the antipsychotic medication olanzapine. | The Journal of clinical psychiatry 19970101 |
| Effects of a cardioselective M2 receptor antagonist, AF-DX 116, on ventricular arrhythmias in dogs. | Heart and vessels 19970101 |
| Muscarinic antagonists microinjected into the subthalamic nucleus decrease muscular rigidity in reserpinized rats. | Neuroscience letters 19960809 |
| Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors. | European journal of pharmacology 19960603 |
| Muscarinic binding sites of the pig intravesical ureter. | Journal of autonomic pharmacology 19951001 |
| A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. | FEBS letters 19940919 |
| Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons. | Brain research. Molecular brain research 19940701 |
| Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes. | British journal of pharmacology 19940601 |
| Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain. | Brain research 19940418 |
| Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice. | Neuroscience letters 19940227 |
| Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors. | The Journal of pharmacology and experimental therapeutics 19921101 |
| AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices. | European journal of pharmacology 19920910 |
| Limbic thalamus in rabbit: architecture, projections to cingulate cortex and distribution of muscarinic acetylcholine, GABAA, and opioid receptors. | The Journal of comparative neurology 19920508 |
| Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes. | Life sciences 19920101 |
| Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors. | The Journal of pharmacology and experimental therapeutics 19911101 |
| Antagonist binding profiles of five cloned human muscarinic receptor subtypes. | The Journal of pharmacology and experimental therapeutics 19910201 |
| Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. | British journal of pharmacology 19910101 |
| Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex. | Neuroscience 19900101 |
| Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. | Molecular pharmacology 19890401 |
| The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes. | Molecular pharmacology 19890401 |
| Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover. | The EMBO journal 19881001 |
| Possible mechanisms of anti-cholinergic drug-induced bradycardia. | European journal of clinical pharmacology 19880101 |
| Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. | British journal of pharmacology 19860901 |
| Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. | Life sciences 19860505 |
| The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes. | Movement disorders : official journal of the Movement Disorder Society 19860101 |
| Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists. | Naunyn-Schmiedeberg's archives of pharmacology 19851201 |
| Gastric cytoprotection by pirenzepine in rats: evaluating method for cytoprotective activity by antisecretory agents. | Japanese journal of pharmacology 19850801 |
| [3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia. | Brain research 19840102 |
Related Products
© 2019 Angene International Limited. All rights Reserved.